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Antigens of 	the rodent 	malaria parasite 
Plasmodium chaL'audi were studied using monoclonal 
antibodies (mcabs). The mcabs were produced by fusing a 
mouse myeloma cell line with spleen cells from mice 
immunized with cloned isolates of the parasite, AS and 
CB. 
The immunoglobulin heavy chain subclasses secreted 
by the hybridoma cell lines were determined by 
Ouchterlony double diffusion using commercially bought 
antisera. 
- The antigens with which the mcabs were reacting 
were analysed by Indirect Fluorescent Antibody test 
(IFA). They were also analysed by immunoprecipitation of 
metabolically labelled extracts of parasites followed by 
SDS-polyacrylamide gel electrophbresis and by Western 
blotting. Many of the mcabs reacted with a 250000 dalton 
protein synthesised in late trophozoites and schizonts. 
Using these and other mcabs provided by Drs. D. 
Boyle and C.Hamers-Casterman, twelve different cloned 
isolates of Pchabaudi were screened using IFA. This 
survey revealed a great deal of antigenic diversity 
between isolates of the same species. This diversity was 
not correlated with the area of parasite origin; two 
isolates from the Congo were dissimilar and were similar 
to isolates from the Central African Republic. 
A genetic cross was carried out between two 
isolates from the Central African Republic, AS and Cs. 
(ii) 
These two isolates were characterised by different 
isoenzyme and drug response markers as well as being 
antigenically distinct. Progeny of the cross were cloned 
and analysed. The antigenic profiles were the two 
parental forms only. This result was also found when 
cloned progeny from a different cross between AS and ER 
were analysed. These results show that the mcabs are 
reacting with different sites on one protein. 
Immunoprecipitates of cross progeny were digested 
by a staphylococcal protease and the resulting peptides 
examined by SOS- polyacrylamide gel electrophoresis. The 
peptide maps obtained for the cross progeny were like 
the parental peptide maps. The 250kDa antigen appears to 
be the product of one gene which has many alleles. 
The gene for the 250kDa antigen was inherited 
independently from another antigen gene recognised by a 
mcab.. Both antigen genes were inherited independently 
from isoenryme and pyrimethamine response markers. 
(iii) 
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1.1 The Problem of Malaria 
Thirty years ago the Malaria Eradication Programme 
was launched by the World Health Organisation (WHO, 
197). It was based on the spraying of residual 
insecticides such as DDT on all indoor surfaces. This 
was intended to break the cycle of infection by killing 
female mosquitoes as they rested after a blood meal.. The 
spraying programme was supported by the use of 
antimalarial drugs such as chloroquine to treat clinical 
cases of malaria. 
However, early success led some countries to stop 
their spraying programmes prematurely. In most 
countries, small foci of infection remained and the 
disease spread back quickly into cleared areas.. Also, 
the effectiveness of some insecticides was reduced. Some 
mosquitoes altered their behavior, others became 
(Gabatdon islz) 
physiologically resistant. New insecticides were used 
but they were more expensive. Pest control of crops also 
used insecticides and this helped the rapid development 
of resistance,, (CkSp!A ad Wesse.rsfrom 1 iWi). 
Parasites were also shown to have developed 
*o an4Imatsri&k 
resistanceA.In 1961, Moore and Lanier reported cases of 
P.falciparum in Colombia with abnormal reactions to 
chioroquine. Within three years resistance to 
chloroquine was found in Brasil, Cambodia, Thailand and 
Vietnam (Peters, 1970). It also spread to East Africa 
(Fogh et al, 1979, Onori et al, 1982). In Thailand, many 
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parasites have multiple drug resistance (Thaithong 	et 
al, 1983). 
Although the original schedules for eradication 
were found to be unrealistic, in the revision of the 
programme in 1969 (WHO, 1969) global eradication was 
still considered to be the ultimate goal to be pursued. 
The methodology of malaria eradication was to be 
- 	 reviewed to develop alternative methods which were 
simpler and less expensive. In 1976 the Special 
Programme for Research and Training in Tropical Diseases 
was launched (Wernsdorfer, 1977). It selected six 
diseases for concentrated attack including malaria. The 
objectives of the programme are to encourage research 
and development of new and improved tools for the 
control of disease and also to strengthen the research 
capability of the tropical countries where these 
diseases are prevalent. 
1.2 Malaria Life Cycle 
Malaria parasites were first observed in the blood 
of a patient by Laveran in 1880. Since then, the rest of 
the complex life cycle of human and many animal species 
of malaria parasite has been described. The work in this 
study has been carried out on the rodent malaria 
parasite Thchabaudi . It was first described by Landau 
(1965) and redefined by Carter and Walliker (1975). 
Figure 1 shows a diagram of the life cycle of 
P.chabaudi . The cycle starts when a female mosquito 
takes a blood meal. Malaria gametocytes are ingested (1) 
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into the midgut, in which the macrogametocyte transforms 
into the female gamete and the microgametocyte undergoes 
exflagellation (2). This process releases male gametes 
which fertilise the female gametes (3). A motile 
ookinete is formed (4 & 5) which penetrates the wall of 
the midgut. This develops into an oocyst which takes 0 
to 15 days to mature (6-9). When mature, the oocyst 
ruptures (10) liberating sporozoites which migrate to 
the salivary glands (11) When the mosquito takes another 
blood meal, the sporozoites are injected into the blood 
stream of the mammalian host. 
The sporozoite circulates in the blood (12) until 
it reaches the liver where it enters a hepatocyte. It 
develops into an exoerythrocytic schizont. This takes 
more than 50 hours to mature (13-15) before rupture and 
release of many exoerythrocytic merozoites (16) into the 
blood stream. 
These merozoites invade erythrocytes (17) and 
undergo further cell division (18-21) to form 
erythrocytic schizonts. P..chabaudi schizonts contain 6 
to 0 merozoites which are released by cell rupture 
allowing the merozoites to reinvade other red blood 
cells. Development of the erythrocytic stages of 
P.chabaudi is synchronous, with each cycle taking 24 
hours. The parasite preferentially invades mature 
erythrocytes. Some merozoites on reinvasion develop into 
gametocytes (1) which circulate in the blood stream 
ready to be ingested by a mosquito. 
Figure 1. Life cycle of rodent malaria. From Landau and 
Boularcl (1978). 
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1.3. Vaccine Studies 
Apart from research into the development of 
insecticides and antimalarial drugs there have been many 
investigations into the immune response to malaria with 
a view to producing a vaccine. Reviews on this subject 
are by Cohen (1979), Desowitz & Miller (1900), Playfair 
(1980), Deans & Cohen (1983), WHO (1984) and 
Bruce-Chwatt (1985). 
The idea that a vaccine could be produced against 
malaria was encouraged by the studies of Cohen et al 
(1961), who showed that antibodies are important in 
suppressing infection of Pfalciparuin and 
P.malariae . These workers gave immune adult gamma 
globulin to twelve Gambian infants with severe clinical 
malaria. They observed that the symptoms of the disease 
were reduced and the parasitaemias reduced to very low 
levels. They found no alteration on parasite morphology 
during treatment. Since only immature parasites are 
detctable in peripheral blood, they deduced that the 
antibody was acting upon mature schizonts or free 
merozoites. This West African serum was also found to be 
protective against East African P.falciparum by 
McGregor et a! (1963), showing that at least some of 
the antigens which induce a protective response are 
shared by separated populations of parasites. Miller et 
a! (1975) have shown that immune serum from 
chloroquine-cured rhesus monkeys 	infected 	with 
Pknowlesi causes aggregation of merozoites in vitro 
They found that antibody inhibited parasite penetration 
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of erythrocytes, possibly by merozoite agglutination. 
Although current studies are aiming at the 
production of a vaccine with defined antigens, 
vaccination studies on malaria using various parasite 
preparations have been carried out for many years. These 
studies have been in two main areas, (1) immunity to 
sporozoites, and (2) immunity to the erythrocytic 
stages, and these are discussed separately here. 
1.3.1. Immunity to Sporozoites 
Mulligan 	et al 	(1941) first 	showed 	that 
inactivated sporozoites could 	induce 	immunity 	to 
P.ga!Zir,aceum Nussenzweig et a! (1972) reviewed 
vaccination studies against mammalian malarias using 
sporozoites and concluded that in all cases irradiated 
sporozoites could be used as effective vaccines. 
However, Collins & Contacos (1972) found that they were 
ineffective in the simian malaria P.cynomolgi . The 
main problem of using irradiated sporozoites as a 
vaccine was that they had to be given intravenously. 
However, Orjih et a! (1981) inoculated irradiated 
P.berghei sporozoites intramuscularly into young and 
adult mice and found good protection in the young mice. 
There was some protection in the adult mice but not as 
great as with intravenous injection. Clyde et al 
(1975) and Rieckman et a! (1979) allowed X-irradiated 
infected mosquitos to feed on human volunteers over an 
extended period of time. Both studies found that this 
induced protection against homologous and heterologous 
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P.falciparum 	challenge but it lasted only a few 
months. 
Clyde et a! (1975) found that the protection was 
species specific and not effective against P.,vivax 
challenge although immunity to P..vivax could also be 
induced by this method. Nussenzweig et a! (1967 & 
1969) found that sporozoite immunity to P.berqhei is 
stage specific and had no effect on the course of 
infection when challenged with erythrocytic stages of 
the parasite. Since the symptoms of the disease are 
caused by the erythrocytic stages of the parasite a 
vaccine would have to be effective against them. 
1.3.2. Immunity to Ervthrocvtic Staoes 
Brown et a! 	(1970) immunised rhesus monkeys 
against P..kr,owlesi using dead parasites, given with 
Freunds Complete Adjuvant (FCA). Two out of three 
monkeys survived the initial parasitaemia after 
challenge and rapidly cleared their infection. Their 
immunity was also effective against another strain of 
P..knoNiesi 	but not against 	another 	species 	of 
Plasmodium . Schenkel el a! (1973) used a non viable 
lyophilized antigen preparation from blood stage 
antigens of P.krsow!esi , and compared its effect on the 
infection in monkeys when given in combination with FCA, 
BCG or nucleotides and aluminium hydroxide as an 
adjuvant. The only effective combination had FCA as the 
adjuvant. Mitchell et a! (1974) used fresh merozoites 
and mature schizonts of P.knoiq!esi with FCA to 
IFA 
inoculate rhesus monkeys. Immunity against challenge 
with the same variant was induced in both systems 
although only the merozoite preparation induced immunity 
to a different variant. Weilde et a! (1979) immunised 
three Aotus monkeys with P.falciparum blood forms 
which had been irradiated. No adjuvant was used and two 
of the monkeys survived for more than 180 days after 
challenge with fresh parasites. 
1.4. Identification of Individual Antigens 
1.4.1 Identification by Immune Serum 
	
Large amounts of antigen are required 	in 
immunization studies. Sporozoites cannot be cultured and 
their isolation from infected mosquitoes 	is 	time 
consuming. 	Although the erythrocytic stages of 
(Trager snd Tansen, 19 It.) 
P.falciparum can be cultured A not all isolates grow 
well. Those that do grow have a low level of 
multiplication and lose their synchronicity. Apart from 
the problems of obtaining enough material for 
immunization, parasite preparations could also include 
unwanted material such as salivary glands or red blood 
cell membranes which might induce autoimmune reactions 
in the recipient. Vaccines ideally require well-defined, 
pure malaria antigens. Thus it is important to discover 
which antigens induce a protective response and which 
induce an ineffective response or even one which is 
harmful to the host. 
Reese et a! (1981) immunoprecipitated metabolically 
labelled proteins of ,°..falciparum 	with immune human 
sera which inhibited parasite growth 	in vitro 	and 
compared these with proteins precipitated by 
non-inhibitory sera. They found proteins of 200kDa, 
75-80kDa and 45kDa precipitated only by the inhibitory 
sera. Perrin et al (1981a) obtained similar results 
but identified two additional antigens of 140kDa and 
llOkDa. However, Brown et a! (1982) found only one 
protein of 96kDa specifically precipitated by inhibitory 
immune serum. Schmidt-Ullrich & Wallach (1978) prepared 
a hyperimmune serum in rhesus monkeys against 
P.kr,ow!esi and identified three proteins specific to 
the membranes of parasitised erythrocytes. 
1.4.2 Identification Using Monoclonal Antibodies 
Although the above methods enable antigens to be 
identified, they do not aid their isolation for use in 
vaccination studies. The advent of monoclonal antibody 
(mcab) technology has enabled many antigens to be 
identified and purified. Kohler & Milstein (1975) 
produced continuous cultures secreting antibody of 
defined specificity to sheep red blood cells using 
Sendai virus as the fusing agent. PEG as the fusing 
agent was used in the production of antibodies to major 
histocompatability antigens (Galfre et a! , 1977) and 
is commonly used in many protocols. The wide 
applications of mcabs have been seen in their use in 
many fields of medical research from cancer and tumours 
to viral and bacterial diseases (Lennox, 1984). They 
have been made against many parasites including malaria, 
trypanosomes, schistDsomes and leishmania (Cohen, 1984). 
Within the field of malaria research, mcabs have been 
used to study different parts of the life cycle 
sporozoites, gametes and blood forms of several 
different species of Plasmodium . Their great advantage 
over previously available reagents has been their 
monovalent reactions to identify individual components 
out of the complex mixture of antigens which makes up 
the parasite. 
Yoshida et al (1980) made a hybridoma cell line 
against sporozoites of P.herahei . Antibodies secreted 
by the cell line bound to a protein round the surface 
membrane of the sporozoites. When sporozoites were 
incubated with antibody in vitro they lost their 
infectivity to mice. When antibody was given to mice 
they were resistant to sporozoite challenge (Potocnjak 
et al , 1980). Using the same mcab, Hollingdale et al 
(1982) could inhibit the entry of sporozoites into 
cultured embryonic lung cells. Inhibitory mcabs to the 
sporozoites of P.knoN1esi were made by Cochrane et 
al (1982). Sporozoites were incubated with antibody for 
60mins before being injected into rhesus monkeys. Five 
mcabs could inhibit infectivity completely. Sporozoites 
incubated with normal mouse serum gave rise to 
parasitaemias in the monkeys 7 days after the injection. 
Nardin et a) 	(1982) made mcabs against the 
sporozoites of the human malarias 	P.'falciparum 	and 
P.vivax . The mcabs were tested for their ability to 
neutralise the infectivity of sporozoites by incubating 
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the sporozoites with various dilutions of antibody proir 
to injecting into splenectomised chimpanzees. The 
P.falciparum 	control 	chimpanzees 	developed 
parasitaemias about 14 days after injection. The 
experimental animals did not develop parasitaemias until 
after day 21, and one had not shown any parasites when 
monitoring stopped on day 61. The experiments with 
P.vivax sporozoites showed that the incabs could delay 
patency of infection and in one out of five chimps no 
parasites were seen upto day 79 when the experiment 
ended. Since primates are scarce, these in vivo 
experiments were correlated with in vitro 	inhibition 
by Hollingdale et al (1984). The mcabs of Nardin 	et 
a! (1982) were tested for their ability to inhibit 
invasion 	of 	cultured 	human 	hepatoma cells by 
sporozoites. Mcabs against P..falciparuin sporozoites 
could inhibit their entry into the hepatoma cells. 
P.vivax sporozoites were inhibited by mcabs raised 
against them. 
Many different groups have produced mcabs against 
antigens of erythrocytic stages of P.falciparum 
P..know!esi , P.chabaudi and P.yoe!ii . Despite being 
produced against different species of malaria,a class of 
proteins with which some of the mcabs reacted was found 
to exhibit similar properties (Newbold, 1984). The Mr of 
these proteins ranged from 190K in P.falciparur to 
230K in Pyoelii and 250K in P.chabaudi and 
P..kr,onlesi 	. They were synthesised late 	in 	the 
erythrocytic cycle and had 	a characteristic 
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immunofluorescence 	pattern 	in 	fixed 	preparations 
reacting with mature schizonts and free merozoites.. 
Although the mcabs did not react with different species, 
a polyvalent mouse serum raised against the purified 
P. yoelii 	protein reacted with 	the 	proteins 	of 
P.falciparum and P.chabaudi ( Holder et al ,(1983).. 
When animals were given mcab or the purified protein, 
with which the mcab reacted, they were resistant, in 
varying degrees, to challenge with blood form parasites 
(Freeman et al , 1980; Epstein et al , 1981; Boyle et 
al , 1982; Hall et a! , 1984a). 
	
Other antigens which may be important 	in 
protective immunity have also been identified by mcabs. 
For example, Deans et al (1982) made rat mcabs against 
P.knowlesi merozoites and identified a surface antigen 
of 66kDa. Fab fragments of the mcabs inhibited invasion 
of erythrocytes by merozoites. Perrin et a! (1981b) 
produced mcabs against P..berqhei and P.fa1ciparum 
which inhibited the growth of P..falciparum in cultul'e. 
The mcabs identified P.falciparui antigens of 41kDa 
and 96 and 36kDa. Stanley et a! (1985) made mcabs to a 
56kDa glycoprotein on the surface of P.falciparum 
merozoites; there was no evidence, however, that this 
antigen was involved in immunity. Miller et a! 	(1984) 
produced several mcabs against P.knowlesi 	These were 
shown to be inhibitory and react to with a protein of 
140kDa. Taylor 	et a! 	(1981) produced 	mcabs 	to 
P.yoelii . Some were stage specific, some were species 
specific, others cross reacted with other rodent malaria 
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species and some even cross reacted with rodent, primate 
and avian malarial species. 
Although a large number of different antigens are 
implicated by mcabs to be involved in protective 
immunity, not all are likely to be incorporated in a 
vaccine. Newbold (1984) discusses this point and the 
problems in using animal model and culture facilities to 
study the problem. Brown et al (1983) have shown that 
- there is no correlation between the known immune status 
of the donor of serum and the ability of the serum to 
inhibit growth of P.falCiPaFUM parasites in vitro 
1.4.3 Identification of Variant Antigens 
lEA has been used to identify variant antigens 
recognised by many mcabs. This technique has many 
advantages. Firstly it can give rapid results, within 2 
hours. Secondly, it can give information about the 
location of the antigen. For example, in different 
species of Plasmodia characteristic lEA patterns are 
seen for the high molecular schizont antigen (Holder et 
al , 1983) and the rhoptry antigen (Oko et al , 1984, 
Howard et a! , 1984, Schofield et a! , 1985). Thirdly, 
the number of parasites reacting per field can indicate 
stage specificity and can identify minority parasite 
populations, down to less than 17. (McBride et a! 
1982) in a mixed infection. 
A panel of mcabs raised against two Thai isolates 
were used to screen a number of 	isolates of 
P.falciparum from different areas (McBride 	et a! 
13 
1982 & 1985). These studies showed a great deal of 
antigenic diversity between the isolates tested with no 
clear regional differences identified. On the basis of 
the IFA reactions of mcabs specific for one antigen, 
isolates could be allocated into one of seven groups or 
serotypes. This antigen ranged in size between 195kDa to 
200kDa in different clones as shown by 
immunoprecipitation (McBride et al , 1985). 
Immunoprecipitation of this antigen in newly isolated 
parasites from the Gambia with these mcabs also showed 
that it varied in size in different isolates (Howard, 
et al , 1986). 
Antigenic diversity of 	Pfalciparum 	was also 
shown by Schofield et al (1982) using mcabs raised 
against two isolates from Papua New Guinea (PNG). These 
mcabs reacted with all PNG isolates tested but did not 
react with isolates from Thailand, Ghana, the 
Netherlands or Nigeria. 
1.5. Molecular Studies on Antioens 
Once the proteins involved in host protective 
immunity have been identified, the next steps are the 
cloning of parasite genes, followed by the expression 
and identification of the genes encoding the proteins. 
The protective epitope may then be produced by genetic 
engineering methods or by chemical synthesis. 
The first malaria gene to be cloned and sequenced 
was the circumsporozoite protein of P..kncnulesi . Ellis 
et al (1983) isolated a cDNA clone which expressed a 
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fusion polypeptide. This reacted with mcabs to the 
circumsporozoite protein. The polypeptide was composed 
of twelve amino acids repeated twelve times. A repeating 
unit was also found in the structure of the 
circumsporozoite protein gene of P.fa1ciparum (Dame 
et al , 1984 and Enea et a! , 1984). 
This repeating unit comprised of four amino acids. 
Peptides comprising of a number of copies of the repeat 
were expressed in E.coli and injected into mice. The 
resulting sera reacted with live sporozoites and blocked 
the invasion of human hepatoma cells by sporozoites 
(Young et a! , 1985). Synthetic peptides which encoded 
several tetrapeptide repeats were also synthesised 
(Zavala et al • 19G5 and Ballou et a! , 1985). The 
peptides were coupled to carriers and injected into mice 
and rabbits. Both groups found their sera could inhibit 
the invasion of hepatoma cells by sporozoites in 
vitro 
The erythrocytic stages synthesise many more 
proteins than the sporozoites and many groups are 
involved in producing gene libraries expressing blood 
stage antigens. Kemp et a! (1983) were the first to 
produce a P..falciparum cDNA library and screen it with 
immune human sera which was known to inhibit parasite 
growth in vitro . The first antigen they identified was 
an S-antigen. Because of the great amount of diversity 
of S-antigens (Wilson et a! , 1969, Anders et al 
1983) it is unlikely to be a candidate in the search for 
a vaccine although Saul et a! , (1985) showed a mcab 
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against an S-antigen could inhibit growth it. vitro 
A P.falciparum protein of Mr 190000 was purified 
using mcabs by Hall et a! , (1984a). Three Saimiri 
monkeys were immunized with purified protein with ECA. 
Two of the monkeys recovered from the parasitaemia 
arising from challenge. The parasites used in the 
challenge were from a different strain than was used to 
purify the protein. Data from mcab reactivity showed 
that the protein had constant and variable regions and 
the immunization data suggested that the constant part 
of the protein may have protective value. The purified 
protein was also used to raise a polyclonal rabbit serum 
for screening their cDNA library made from the Thai 
isolate Ki. They isolated a clone containing 300 base 
pairs of the gene. A further part of the gene was 
obtained by Cheung et a! , (1985), who used the isolate 
SGE2 from Zaire. The whole of the protein from the 
Wellcome West African isolate was sequenced by Holder 
et a! (1985). 
The entire 1<1 sequence was reported by Mackay et 
a! (1985) and the sequence for an isolate from PNG, MAD 
20, was reported by Tanabe et a! (1986) who also 
compared the sequences which have been identified. Apart 
from the N-terminal signal peptide and the C-terminal 
region which is rich in hydrophobic amino acids they 
were able to divide the gene into blocks. Some of the 
blocks are highly conserved with greater than 87% of the 
amino acids homologous between the isolates. In some 
blocks the sequences appear to have diverged and have 
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less than 407. homology. The remaining blocks appear to 
be conserved sequences with patches of non-homologous 
residues. It is not yet known which of the blocks encode 
the epitopes which induce the protective response shown 
by Hall et al (1984a). However, since they were able 
to protect against a heterologous challenge it is 
probably in one of the conserved regions. 
Coppel et al (1984) identified an antigen of 
P.falciparum on the surface of ring-infected 
erythrocytes. Perlmann et al 	(1984) showed 	that 
antibodies to the same antigen inhibited parasite growth 
in vitro . The sequence of the protein revealed two 
regions of repetitive sequence. 14 Aotus monkeys were 
immunized with recombinant polypeptide in FCA and 9 
monkeys recovered from challenge (Collins 	et al 
1986). 
	
Koenen et a! 	(1984) isolated a clone of an 
antigen on the membrane of erythrocytes infected with 
mature parasites not rings. This protein was composed of 
9 amino acid repeats. Stahl et a! (1985) identified 
another clone recognised by human immune serum. This 
protein had repeats of 6 amino acids interspersed with 
regions containing both acidic and basic amino acids 
Antibodies to this protein react with mature and 
immature parasites but not the surface of the 
erythrocyte. 
Hope et al (1984) found cross-reaction between 
sporozoites and blood stages using a mcab. When they 
sequenced the gene from the erythrocytic stage, they 
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found a sequence of 15 amino acids which had homology to 
the tandemly repeated tetramer of the circumsporozoite 
protein (Hope et al , 1985). The common epitope 
probably lies within this small sequence. 
Several other genes of malaria parasite have been 
sequenced (Kemp et al , 1986, Scaife et a! , 1986). 
The most notable feature of many of the genes so far has 
been the presence of repeated units. The function of 
these is not yet known. The sequence of the repetitive 
units of proteins expressed in the erythrocytic stage 
shows a great deal of diversity. Often repeated units do 
not cross-react with other isolates although 
non-repetitive parts of the same protein do cross-react 
(Cowman et a! , 1985). 
Molecular vaccines do have certain limitations 
(Mitchell, 1984). There is the requirement of adjuvants 
or antigen delivery systems. There is also the problem 
that a vaccine of restricted composition could select 
parasites which do not express the antigen. Guidelines 
have been published for the field trials of the vaccines 
(WHO 1986). 
1.6. Genetics of Malaria Parasites 
There are many species of malaria, four of which 
infect humans. Although each species is distinct, there 
is a great deal of variation within species. Studies of 
the genetics aim to show the mechanisms through which 
this variation arose and how it spreads. Until recently 
it was not possible to study the genetics of human 
malarias so the convienient model of the rodent malarias 
was used. Reviews on malaria genetics are by Beale 
(1980) and Walliker (1983). 
The method used for carrying out genetic crosses 
is to allow mosquitoes to ingest a blood meal containing 
gametocytes of two cloned lines. When mature sporozoites 
are present in the salivary glands the mosquitoes are 
fed on an uninfected host. The resultant infection will 
contain a mixture of the progeny of self and cross 
fertilization. Individual progeny are cloned by diluting 
infected blood and injecting a single parasites into a 
host. 
The fundamental question of ploidy was one of the 
first problems studied by genetics. Variant forms of 
parasite enzymes revealed by electrophoresis were shown 
to be stable markers. When Rosario (1976) crossed two 
lines of P.chaL'audi which differed in two enzymes, 
four types of progeny were produced. Two were the 
parental types and two were new combinations of the 
enzyme forms. The conclusion was that the blood forms 
were haploid. If they were diploid then three types of 
progeny would be predicted from the cross, the two 
parental types and one hybrid with both types of each 
enzyme. 
The use of enzymes enabled the identification of 
species and sub-species of malaria (Carter 1978). 
Genetic studies in the laboratory have shown that 
interbreeding within the species P.yoelii can occur 
(Knowles et al , 1981 and Lainson 1982 & 1983a). If 
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populations in the wild can interbreed freely then 
characters such as drug resistance and variant antigens 
will have no barrier to their rapid spread. 
Crosses between parasite lines of 	P.yoelii 	and 
P.chabaudi resistant and sensitive to pyrimethamine 
showed segregation of the pyrimethamine response and 
recombination with isoenzyme markers (Walliker et al 
1973 and 1975). The conclusion was that resistance was 
probably due to a single mutation. Pyrimethamine 
resistance in Pfalciparum arose rapidly in areas 
where the drug was used, indicating that the resistance 
had a similar mechanism in rodent and human malarias. 
The results of chloroquine resistance studies 
showed a quite different picture. When a P.chabaudi 
line resistant to a high level of chloroquine was 
crossed to a sensitive line, a range of levels of 
resistance was found in the resulting clones (Padua 
1981). The conclusion from this was that the high level 
of resistance was due to an accumulation of several 
mutations at different loci. The use of chloroquine as a 
prophylactic probably provided ideal conditions for the 
selection of resistance to the drug in P.faiciparuvi 
The first study of the inheritance of antigens of 
malaria parasites was by Panton et al (1984). Using 
crossed-immunoelectrophoresis they identified an antigen 
of P.yoelii , Pyl, whose quantity and electrophpretic 
mobility differed between lines. Results from a cross 
showed that the quantity of the antigen correlated with 
the virulence of the parasites. The electrophoretic 
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mobility of Pyl segregated independently of the 
virulence character. The two antigenic markers also 
recombined with isoenzyme and drug sensitivity markers. 
Although more characters of P.falciparum such as 
variant proteins identified by 2D-PAGE (Fenton et a.! 
1985) and mcabs (McBride et al , 1982) have been added 
to the isoenzymes and drug response markers, no linkage 
groups have been identified. Sinden 	(1978) 	using 
cytological data suggested a haploid number of 10 
chromosomes. Pulse field gel electrophoresis (PFBE) used 
by Kemp €t al (1985) gave an estimate of at least 8 
chromosomes in Pfa1cipartn . The same technique has 
separated at least 10 chromosomes in 	P.chaL'audi 
(A.Sharkey, unpublished). 
Studies on the variation of characters when added 
to the knowledge of how these characters are inherited, 
are very important in control measures. Studies on the 
genetic basis of drug resistance have shown how drug 
resistant mutations could arise and spread through the 
parasite population which is largely interbreeding. In 
the development of a vaccine, studies on the genetics of 
antigens could provide information enabling predictions 
to be made about the likelihood of new forms of antigen 
arising and spreading through the population as a result 
of the selection pressure. 
1.7. Aims of This Work 
Many groups of research.workers are concentrating 
on identifying and cloning the genes of protective 
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antigens of malaria with a view to producing a vaccine. 
However, very little is known about the ability of 
malaria parasites to generate new antigens. Antigenic 
variation in P..knowlesi (Brown & Brown, 1965, Howard 
et al , 1983), P.,chabaudi (McLean et a! ,1982) and 
P.fa1ciparum (Hammel et a! , 1983) was identified 
using sera. Using mcabs, McBride et a! (1982) and 
Schofield et a! (1982), have shown antigenic diversity 
of individual antigens within P.,falciparuw . Mackay et 
a! (1985) and Schwartz et a! (1986) have shown 
diversity of an antigen at the DNA level. It is 
important to study how new forms of antigens can arise 
so that the response of the parasite population to the 
selection pressure, which a vaccine would induce, could 
be predicted. Genetic studies of P.falciparum were not 
possible until recently. Rodent inalarias are useful 
models with which to study the genetics of the parasites 
(Walliker, 1983). Panton et a! (1984) used 
crossed-immunoelectrophoresis to study the genetics of 
P.yoe!ii antigens. 
The aims of this study were 
1) to identify variant antigens in the rodent malaria 
species P.chabaudi . For this part of the project, 
mcabs were prepared from mice infected with 
P..chabaudi and screened against a variety of cloned 
parasite lines using lEA. This was expanded by the 
use of mcabs from other laboratories also made 
against P..chabaudi 
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to characterise the antigens with which the mcabs 
reacted by immunoprecipitation 	of 	metabolically 
labelled parasite proteins and digestion of the 
immunoprecipitates by a protease. 	Blotting of 
proteins on nitrocellulose membranes was also used. 
to study the genetics of the variant antigens in 
crosses between clones differing in these antigens. 
This was to determine whether diversity was due to 
allelic variation of a single gene or diversity of 
genes at different loci. It was also to determine if 
there was any linkage between antigen markers and 
isoenzymes and pyrimethamine response. 
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2 MATERIALS AND METHODS 
2.1 Laboratory Hosts 
2.1.1 Rodents 
Most of the mice used in this study were bred and 
housed in the Department of Genetics, University of 
Edinburgh. Some C57B1 mice and white rats were obtained 
from the University of Edinburgh Centre for Laboratory 
Animals. 
C578l mice were used for all routine parasite 
passages and preparations. Mixed outbred strains of mice 
were used in cloning experiments. All hybridoma work was 
carried out using Balb/c mice. 
Rodents were supplied with a diet of pelleted rat 
cake (B.P. 1). Drinking water was supplemented with 
0.05% w/v para-aminobenzoic acid (PABA) to aid parasite 
growth (Jacobs, 1964). 
In experiments requiring parasites in the late 
stages of the erythrocytic cycle, mice were kept in a 
reversed light regime with illumination between 5.30pm 
and 8.30am! under these conditions, schizogony of 
P..chabaudi occured during the daytime. 
2.1.2 Mosquitoes 
Anopheles stephensi were maintained in a 12 hour 
light, 12 hour dark cycle at 24-26°C with BO% relative 
humidity. They were supplied with 10% glucose solution 




In this work parasites are described as isolates 
and clones, the definitions of these terms are as 
follows. 
Isolate. A sample of parasites collected from a 
naturally infected host on a single occasion. Parasites 
within the sample are not necessarily genetically 
homogeneous. 
Clone. Genetically homogeneous parasites which are 
derived from a single cell by asexual division. 
2.2.2. Parasite Lines 
Most of the parasites used in this work (Table 1) 
were from a collection of P.chahaudi described by 
Carter and Walliker (1975) and Carter (1978) which is 
maintained in Edinburgh in liquid nitrogen. Two 
additional lines were FE (Lainson, 1983b) and ER which 
was sent to this laboratory by C. Hamers-Casterman as an 
isolate designated 56L. All parasites had been cloned by 
limiting dilution before this study (2.2.5.). 
The main parasites used in this work were AS, CD 
and ER which had been isolated in the Central African 
Republic (CAR). The CB line used was a pyri methami ne 
resistant line, which was selected by D.Walliker by 
treating infected mice with 30mg/kg pyri' nethamine over 
four days and then cloning the surviving parasites by 
limiting dilution. AS and ER were both sensitive to 
pyrimethamine. 
Table 1. Origin of Parasites 
Line Country Species & 
of Origin sub-species 
AS C.A.R. P..c.,chabaudi 
CB C.A.R. P.cchabaudi 
ER C.A.R. P.chat'audi 
AF C.A.R. P.,c.,chabaudi 
AJ C.A.R. P.c.chabaudi 
AL C.A.R. P.c..chabaudi 
AD C.A.R. Pc.chabaudi 
BE C.A..R. P..c.chabaudi 
CR C.A.R. P..c..chabaudi 
DX Congo P.cadami 
05 Congo P..c.,adami 
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2.2.3. Estimation of Parasitaemia 
Thin films of tail blood were fixed with methanol. 
They were then stained with lOX GiemsáS stain in 
distilled water (pH 7.2) for 45 minutes or with 507. 
Giemsa for 5 minutes. Parasitaemias were expressed as a 
percentage of the number of parasites in 1000 red blood 
cells. 
2.2.4. Passaging of Parasites 
Routine passages of parasites used citrate saline 
(0.97. NaCl, 1.57. Na citrate, pH 7.2) as the diluent of 
parasitised blood. The inoculum was given through the 
peritoneum. 
When a predetermined number of parasites per 
inoculum was required, the number of red blood cells per 
ml of blood was determined using a Coulter Counter. The 
product of this and the parasitaemia gave the number of 
parasites per ml. Dilution steps using 50% foetal calf 
serum (FCS) in RPI'1I medium 1640 were carried out until 
the required number of parasites per inoculum of 0.lml 
was achieved. 
2.2.5. Limiting Dilution Cloning of Parasites 
To minimize the number of erythrocytes containing 
more than one parasite, mice with parasitaemias of 1-2% 
were used as donors.. A sample of infected blood was 
serially diluted in 507. FCS in RPMI until there was 0.5 
or 1 parasite per 0.lml inoculum. This was given 
intravenously. 
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2.2.6. Cryopreservation of Parasites 
Blood from an infected mouse was mixed with 
heparinised balanced salt solution, pHS and glycerol by 
the method of Lumsden et al (1966). The mixture was 
sealed in glass capillaries and stored in liquid 
nitrogen. 
Infections were re-established by rapid thawing of 
capillaries in water at room temperature. The 
capillaries were cut open and the infected blood was 
mixed with citrate saline before intraperitoneal 
injection into mice. Infections became patent in mice 
within 4 to 7 days and were passaged at least once 
before being used in experiments. 
2.3. Conductinu a Cross 
	
The method for crossing 	P..chabau'Ji 	clones was 
based on that of Walliker, Carter and Sanderson (1975), 
and is illustrated in figure 2. Blood forms of the two 
parasite lines were mixed in proportions estimated to 
result in an equal number of gametocytes from each 
parent line. The mixture was inoculated intravenously 
into a 4-6 week old splenectomised white rat, which 
enhances gametocyte development of P.chabaudi (McLeod 
& Brown, 1976). Maximum numbers of gametocytes were 
found 4 days after inoculation. The animal was 
restrained and placed in a cage containing 7-10 day-old 
1&.stephensi . Feeding was encouraged by depriving the 
mosquitoes of glucose 24 hours prior to the blood meal. 
Figure 2. Procedure used in making a cross 
Parent line A 	 Parent line B 
1 
2 mice 	 2 mice 
No 	No2 	)-Blood forms mixed 	Nol No2 
Jr 	 I .1 
Rat Rat 	 Rat 
.1 Jr 	 I 
Mosquitoes 	 Mosquitoes 	 Mosquitoes 
Mouse 	 use 	 Mouse 
Control line A 	Progeny of the cross 	Control line B 
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The course of the resulting infection was followed 
by examining midgut preparations of mosquitoes 7 days 
later. The number of nocysts gave an estimation of the 
relative success of the parental lines and mixture in 
establishing 	infections. 	When 	large 	numbers 	of 
sporozoites were detected in the salivary glands, 
usually 14 days after the initial infection, 	the 
mosquitoes were allowed to feed on uninfected mice. 
Infections in mice became patent within 7 days. 
2.4 Studies on Blood Form Antigens 
Antigens were studied by immunofluorescence and 
also SDS-PAGE (see section 2.6.4) after metabolic 
labelling of parasite proteins. 
2.4.1 Antigen Preparations for IFA 
Blood from mice with 10% parasitaemia containing 
trophozoites and schizonts was collected 	into 
I 	heparinised RPMI. The blood cells were passed over a 
prewetted column of Whatmans CFI1 powdered cellulose to 
remove white blood cells (Homewood and Neame, 1976). The 
a# (0009 
blood cells were pelleted by centrifuqationand washed a 
further two times in RPMI. The cell pellet was diluted 
in RPMI to 1% by volume. A 20s1 sample was placed on 
each of the wells of PTFE coated slides and allowed to 
dry, before being stored at _200C. 
The preparations were used in IFA by the method 
described in section 2.5.4. 
2.4.2. Metabolic Labelling of Parasite Proteins 
2.4.2.1 Labelling Parasites In Erythrocytes 
Parasites were labelled with 	S-methionine by 
modifications of the method of Newbold et al (1982). 
Blood from a mouse with a 20-30% parasitaemia was 
collected into heparinised RPMI. This was run through a 
prewetted CF1I column to remove white blood cells and 
washed twice with RPMI. The infected red blood cells 
were washed once in Eagles MEM without methionine (MFM). 
The pellet was resuspended in MFM with 107. FCS to give 
10% haematocrit. lOOpCi S methionine was added to 
the culture which was kept in an atmosphere enriched in 
carbon dioxide at 37°C for two hours. 
The free methionine was removed by two washes in 
RPMI. Radiolabelled parasite proteins were extracted 
with lml 17. Triton X-100 in 50mM Tris-HC1 buffer, pH 
8.0, containing 5mM PMSF and 5mM EDTA for lhr at 4°C 
with intermittent vortexing. The mixture was centrifuged 
at 1L000gi) for 30 mins to remove insoluble material. 
Extracts were stored at -70°C. 
2.4.2.2 Labelling Parasites Freed From Erythrocytes 
Parasites freed from their host cells were 
labelled by the method of Tait (1981). After removal of 
the white blood cells and washing the erythrocytes twice 
(as above)ove) theerthyrocytes were lysed with an equal 
volume of 0.15% saponin in RPMI at 37°C for lOmins. 
lOml of RPMI was added and the mixture centrifuged at 
for 7mins. The supernatant and layer of red cell 
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ghosts were discarded and the parasites were washed a 
further two times in RPMI then once in MFM. Parasites 
were resuspended in lml of MFM with 107. FCS. lOOpCi 
S methionine was added and the culture incubated for 
2hrs at 37°C. 
Parasites were centrifuged and washed twice with 
RPMI before being solubilised in extraction buffer (17. 
Triton X-100 in 50mM Tris-HCJ pHB with 5mM EDTA, 5mM 
EGTA, 2mM PMSF). This was incubated at 4°C for lhr 
with intermittent mixing. Insoluble material was removed 
by centrifugation at lir0009: for 30mins. Extracts were 
stored at 70°C. 
2.5. Monoclonal Antibodies 
Mcabs were produced in this study by fusing spleen 
cells from mice which had been infected with the blood 
stages of P.chabaudi to a mouse plasmacytoma line. The 
resulting cell lines were tested for their production of 
antibody to parasites by an Indirect Fluorescent 
Antibody test (lEA). Mcabs against P.chabaudi from 
other laboratories were also used in this study. Details 
are given below. 
2.5.1. Immunization Protocol 
Six week old female Balb/c mice were inoculated 
with lxlOt parasites intraperitoneally. Five days 
later, smears of tail blood were examined to show that 
the mice were infected. Eight weeks after inoculation, 
108 parasites were again injected intraperitoneally. 
-r 
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Three days later mice were bled out and the spleen was 
removed for the fusion process. 
2.5.2 Fusion Protocols 
Two slightly different modifications of the method 
described by Galfre et al (1977) were used in this 
study. 
2.5.2.1. Fusion 3 Protocol 
5x107 P3-X63--NS/1 cells, a mouse plasmacytoma 
cell line (Kohler et al ,1976), were mixed with lxlC'° 
spleen cells from a mouse immunised with P.chabaudi 
line AS. The mixture was centrifuged at 5005j. for 5 
mins and the supernatant was discarded. lml of 50% 
polyethylene glycol 1500 (PEG) in RPMI was added over 1 
Mn. lml of RPMI was added over the next minute. 9mls of 
RPMI were added over 5 mins. The cells were centrifuged 
at .50051S for 5 mins. The pellet was resuspended in 
RPMI with 207. FUS and the uninfected spleen cells were 
added. 0.5m1 aliquots were plated out in each well of 
five 24-well plates. 
24 hours later, 0.5 ml double strength HAT 
solution (1x10M hypoxanthine, 4x10 711 aminopterin 
and 3x10M thymidine) was added to each well. 1 week 
later, 0.5ml culture supernatant was replaced with 
single strength HAT solution. 
2.5.2.2. Fusion 12 Protocol 
1x107 P3-X63-AgG.653 cells, 	another 	mouse 
plasmacytoma cell line (Kearney 	et al , 1979) , were 
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mixed with lxlO° spleen cells from a mouse immunised 
with P.chabaudi line CB. The mixture was centrifuged 
at COg'y: for 5 mins. and the supernatant was 
discarded. 0.5ml 41.6% PEG, 157. DMSO in RPMI was added 
dropwise over 1 min. 0.5 ml 25% PEG was similarly added. 
30mls of RPMI with in. FCS (RP15) containing uninfected 
spleen cells was added slowly to the tube. 0.1 ml 
aliquots were plated out into each well of S 96-well 
microtitre plates. 
24 hours later, 0.1 ml of double strength HAT 
medium was added to each well. 7 days later, 0.lml of 
culture medium was replaced with single strength HAT 
medium. 
2.5.3. Preparation of Feeder Cells 
Cells growing in cultures grow best at known 
densities. Cells secrete factors into the culture 
medium. When the cell density is high, cells go into 
stationary phase. If the cell density is low, the cells 
are not receiving enough growth stimulating factor and 
do not grow very well. To overcome this problem when low 
numbers of cells are plated such as after fusion or 
during cloning, supplementary cells or feeders are added 
to the cultures. Three types of cells were used in this 
study. Spleen cells from a mouse which had not been 
infected were used during the plating out of newly fused 
cells. When cloning antibody producing cells, thymocytes 
or peritoneal exudate cells were used. 
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2.5.3.1. Uninfected Spleen Cells 
The spleen was placed in a moist sieve and cut 
into small pieces. The piston of a syringe was used to 
break up the pieces. Cells were washed through the sieve 
with RPMI. The cells were centrifuged at SOO.- for 
Zmins and resuspended in lOmls RPMI for counting. 
2.5.3.2. Thymocytes 
The thymus was removed from 4-6 week old Balb/c 
mice. It was placed in a moist sieve and teased with the 
piston of a syringe. Cells were washed with RPMI before 
being centrifuged at 5009 for 5 mins and resuspended 
in RP1S. 
2.5.3.3. Peritoneal Exudate Cells 
A window of skin was removed from the peritoneal 
area of 6-12 week old BalbJc mice. 5ml RPMI was injected 
into the peritoneal cavity. The cavity was palpitated 
for 5 mins before withdrawing the peritoneal fluid. This 
was centrifuced at SOOgi. for 5 mins, resuspended in 
lOmls RP15 and plated out in lOOpl  aliquots per well of 
96 well microtitre plate. 
2.5.4. Indirect Fluorescence Antibody Test (IFA) 
IFA was used to screen the supernatants of growing 
cell cultures. The initial screen was carried out two 
weeks after the fusion and repeated twice before 
cloning. The supernatants of cloned cells were screened 
twelve days after the cloning and every few days as the 
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cells were expanded into culture flasks. IFA was also 
used later for screening diversity between different 
parasite lines. 
Multispot slides of antigen preparations (2.4.1) 
were removed from the deep freeze and fixed immediately 
in acetone for Smins. Slides were air dried, and 25pl of 
culture supernatant or serum dilution was placed on each 
spot. Serum from the mouse used in the fusion or 
supernatant known to be positive were used as positive 
controls. The negative control was normal mouse serum. 
The slides were incubated at room temperature for 30mins 
in a humid box. Supernatants were removed and the slides 
were given 3 washes in phosphate buffered saline pH 7.2 
(PBS) for 1,2 and 5mins before being dried gently on a 
hotplate. lOpl of FITC congugated rabbit anti-mouse 
(SmcC) 
whole IgeAwas placed on each spot and incubated in the 
humid box for 30mins. The slides were washed 3 times in 
PBS before counterstaining with 0.17. Evans blue in PBS. 
Preparations were examined using a Leitz Dialux 20 
microscope. The FITC fluorescence was visualised using a 
Leitz filter N2-1. 
2.5.5. Limiting Dilution Cloning of Hybridoma Cells 
Once a colony of cells secreting a desired 
antibody covered more than half of the bottom of well, 
the cells were suspended and a sample was counted. 
Cultures were diluted to 40 cells per ml. The dilution 
was made into RP15 with either thymocytes or peritoneal 
exudate cells as feeders. Further dilution steps were 
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made to obtain 20, 10 and S cells per ml. Each quarter 
of a microtitre plate was plated with O..lml aliquots of 
the dilutions. One week later, each well was fed with 
0.1ml of RP15. Colonies of cells were screened for 
antibody production 5 days later. 
2.5.6. Cryopreservation of Cells 
Cloned cell lines were grown up in 25cm 	flasks 
holding lOmls of culture at 1-3x10 cells per ml. The 
cells were centrifuged at 500> for Smins. 	The 
supernatant was collected and stored with the addition 
of 10mM sodium azide. The cell pellet was resuspended in 
a small volume of supernatant before the addition of Xml 
of 207. DM90 in RPMI with 507. FCS. The suspension was 
placed in a Sail screw cap freezing vial. The vials were 
put in a polystyrene box and frozen for lhr at -20°C, 
overnight at -70°C before being placed in liquid 
nitrogen. 
2.5.7. Production of Ascites 
Balb/c mice were injected with 0.5ml 2,6,10,14-
tetrainethylpentadecane (Pristane) intraperitoneally. At 
least 4 days later 2x10t cells were centrifuged at 
c500. for Smins. The supernatant was removed and the 
pellet was resuspended in 0.3ml of supernatant. This was 
injected into the peritoneum. 
When tumours arose, the fluid was tapped using an 
lBg needle. The mouse was tapped again 2, and 4 days 
after the first collection. The ascitic fluid was 
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centrifuged at 11000q for 7mins to pellet any cells and 
stored at -20°C with the addition of 10mM sodium 
azide. 
2.58. Analysis of Immunoglobulin Subclass of Antibody 
Culture supernatants were concentrated lOx using 
centricon 30 microconcentrators (Amicon). Thésewere used 
in a double diffusion test (Ouchterlony 1978) with goat 
antiserum to the mouse immunoglobulins IgA, IgBl, IgG2a, 
1g62b, 1q63 and 1gM (Serotec). The reactions were 
carried out overnight at 4CC. 
2.5.9. Monoclonal Antibodies from other laboratories 
Monoclonal antibodies which were known to react 
with a high molecular weight antigen (Mr 	250000) 
associated with schizonts of 	P.chabaudi 	were kindly 
supplied by two other laboratories, as follows:- 
Dr D. Boyle (NIMR, Mill Hill, London) supplied 11 mcabs. 
They had been raised against the AS line of P.chabaudi 
(Boyle et al , 1982) which came originally from this 
laboratory. They were referred to by their given number 
prefixed with a B eq 81. 
Dr.C. Hamers-Casterman (Vriie Iiniversiteit 	Brussel, 
Belgium) raised mcabs against the 56L isolate of 
P.,chaLiaudi - 7 of these mcabs reacted with the high 
molecular weight schizont antigen. Their given number 
was prefixed by H. 
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2.6 Antigen Characterisation 
The antigens with which the mcabs reacted were 
characterised by several techniques. 
2.6.1 lEA 
IFA was used to characterise P.chabaudi antigens 
cytologically and to screen for diversity of antigens 
between different parasite lines. 
Most parasite preparations were examined with 
individual mcabs (2.5.4). In some instances, the 
uncloned progeny of crosses were examined by a double 
fluorescent antibody test, in order to show the presence 
of two antigenic determinants in the same parasite 
preparation. For these tests, preparations were 
incubated with two mcabs, of different isotypes. The 
isotypes of the mcabs examined in this procedure were 
either IgG2a or IgS2b. The preparations were then 
stained with fluorescein (FITC) and rhodamine (TRITC) 
i&ctjpe 
conjugated reagents specific for 	each mcabL. The 
procedure was as follows:- 
Multispot preparations of antigen (2.4.1) were 
removed from the deep freeze and fixed in acetone for 
Smins and then air dried. 25pl of a mixture of two mcabs 
of different isotypes was placed on the antigen spots. 
The slides were incubated in a humid box for 30mins at 
room temperature. The supernatants were removed and the 
slides were washed three times in PBS before being dried 
on a hotplate. lopi of either fluorescein congugated 
rabbit anti-mouse IgB2a, rhodamine congugated rabbit 
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anti-mouse IgG2b or a mixture of the two was placed on 
the spots and incubated in the humid box for 30mins. 
Slides were washed in PBS three times before a coverslip 
was mounted with 50% glycerol in PBS. 
Preparations were examined using a Leitz Dialux 20 
microscope. The rhodamine fluorescence was visualised 
using a Leitz N2 filter and an N2-1 filter was used for 
the fluorescein fluorescence. 
2.6.2 Immunoorecinition of Parasite Proteins 
To identify the size of the antigen with which the 
mcabs reacted the antibody was allowed to bind to 
parasite proteins. The complex was collected onto 
protein A bound to sepharose and electrophoresed on a 
sodium dodecyl polyacrylamide gel (5DB-PAGE). The 
parasite proteins had been labelled with S 
methionine so they could be detected by autoradiography. 
Protein A-sepharose was swollen in 50mM Tris-HC1 
pH8.0, 1mM EDTA, and 0.5% Triton X-100 (TET) and 
resuspended at 50% swollen gel volume in the same 
buffer. 
Extracts of parasite proteins labelled with 	S 
(2.4.2) containing 5x10 	cpm were preabsorbed with 
SOul of protein A-sepharose for 30mins at 4°C. The 
protein A-sepharose was removed by centrifugation at 
1t000gc for 3mins. The extract was then mixed with lOpl 
of ascitic fluid and rotated for 2hrs. lOOpl of protein 
A-sepharose in TET+67.BSA was added and rotated for a 
further hour. 
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The immunoprecipitates were washed 3 times in TEl 
with 0.5M NaCl and 17. BSA then twice in TET. lml of 
buffer was used for each wash and the protein 
A-sepharose was spun down at 11000gSv3 for 3mins. The 
addition of the new wash resuspended it. The washed 
complexes were dissolved in 50V1 of 2x sample buffer, 
containing 27. SUS, O.1M Tris-HC1 pH7.5, 107. 
mercaptoethanol, 4mM PMSF, 2mM EDTA and 10% glycerol, 
and boiled for 3mins. The protein A-sepharose was 
removed by centrifugation. Samples were loaded and run 
on 107. SDS-PAGE. (2.6.4). 
2.6.3. Peptide Mapping 
Some of the mcabs reacted with different parasites 
to give a large antigen as the main product of the 
immunoprecipitate. To study this antigen further, after 
immunoprecipitation it was digested by a protease and 
the products electrophoresed on SDS-PAGE. 
Aliquots of 	S-labelled parasite extracts 
containing lxloacpm were immunoprecipitated as 2.6.1. 
After the washing steps the immune complexes were eluted 
by the addition of 200pl of 0.125M Tris-HCl pH6.8,0..57. 
SDS, 10% glycerol and boiling for 3mins. The protein 
A-sepharose was removed by centrifugation. 	60pg/ml 
protease from Staphylococcus aureus strain VS was 
added to the immunoprecipitates and incubated at 37°C. 
Samples were removed at time points 0, 1, 5 and 30 mins 
after the addition of the protease, before being added 
to SUEd  of 2x sample buffer and boiled for 3mins. The 
samples were loaded onto 12.57. SDS-PAG (2.6.4). 
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2.6.4. Western Blotti n g 
This technique involves the separation of parasite 
proteins by electrophoresis and the transfer of the 
separated proteins to nitrocellulose. Mcabs can bind to 
the antigens with which they react and this is 
identified by an antiserum to mouse 1q13 which is 
conguqated to horseradish peroxidase. A chemical 
reaction identifies the site of mcab binding. 
Parasitised blood was collected from an infected 
mouse and passed down a prewetted CF11 column to remove 
white blood cells. The red blood cells were washed twice 
with RPtII before being lysed with an equal volume of 
0.15% saponin in RPMI. lOml of RPI1I was added to the 
suspension and it was centrifuged at 4000rpm for 7mins. 
The parasite pellet was washed in RPMI a further two 
times before being solubilised in 2x sample buffer and 
run on a 7.5 or 107. SDS-PAG (2.6.4). Proteins were 
transferred electrophoretically to nitrocellulose 
filters by 200mA for Shrs (Towbin et al , 1978). 
Non-specific binding sites on the nitrocellulose 
were blocked by incubating the filter for lhr in BLOTTO 
(5% non-fat milk powder in PBS, 0.027. Nah6, 0.057. 
Tween 20) at room temperature. It was then incubated 
overnight with 1/50 dilution of ascites in BLOTTO. The 
first antibody was rinsed off with PBS then two washes 
in PBS with 0.17. Tween 20. 
The blots were next incubated in 1/400 dilutio of 
(Scot4 Mrdba Trooctën Qn+ CarIuk 
horseradish peroxidase conjugated anti-mouse IgGin PBS 
with 0.057. Tween 20 for 4hrs. This second antibody was 
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rinsed off with PBS followed by two washes in PBS with 
0.17. Tween 20 then one wash in Tris-saline (10mM Tris, 
pH7.4, 0.97. NaCl). They were then developed in 0.5mg/ml 
4-chloronaphthol in Tris-saline with 0.01% hydrogen 
peroxide for 5-10mins and washed ih distilled water. 
2.6.5. Polvacrylamide Gel Electrnhoresis (PAGE) 
This was carried out with slight modification to 
the method of Laemmli (1970) using discontinuous buffer 
system. The ratio of acrylamide to bisacrylamide was 
29.2: 0.G. The resolving gel was made with 0.37M 
Tris-HC1 pH8.7, 7.5, 10 or 12.57. acrylamide, 0.17. SOS, 
0.0327. Ammonium Persulphate and 0.00027. TEMED. Once the 
resolving gel was poured it was overlaid with 0.17. SOS. 
When the gel had set s the overlay was removed and 
the top of the gel was washed with water and dried. The 
stacking gel was poured on top. It comprised of 0.11M 
Tris-HC1 pH6.75, 4.37. acrylamide, 0.17. SOS, 0.0367. 
Ammonium Persulphate and 0.00057. TEMED. A 10 or 15 slot 
former was placed in position when the stack was poured. 
When the stacking gel had set the former was removed and 
the wells were rinsed with electrode buffer. The 
electrode buffer contained 0.025M Iris, 0.194M glycine 
and 0.17.505. 
Samples were loaded into wells and the apparatus 
was assembled. The tanks were filled with electrode 
buffer and air bubbles removed from the bottom of the 
resolving gel. Tracking solution of 107. glycerol, 0.002% 
bromophenol blue was added to the top of the wells. 
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Electrophoresis was carried out at constant current of 
6mA per gel for 15-18hrs. 
2.6.6 Processing of Gels 
Gels were fixed and stained by immersion in 0.37. 
Coomassie Brilliant Blue, 50% methanol and 7.5% acetic 
acid for at least 6hrs. The gels were then destained 
with several changes of 40% methanol and 10% acetic 
acid. After destaining they were reswollen in 5% 
methanol and 7.5% acetic acid. 
Swollen gels were fluorographed using the method 
of Laskey & Mills (1975). Gels were shaken in three 
changes of DM50 for 30mins each and then in 22.27. PPO in 
DM50 for 3hrs. They were washed in several changes of 
distilled water for at least lhr. 
Fluorographed gels were dried onto Whatman 3MM 
paper using an LKB gel drier for lhr. The dried gels 
were exposed to pre-flashed Kodak X-Omat AR film (Laskey 
& Mills, 1975) or Kodak X-Omat S film. Film and gel were 
exposed at -70°C. 
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3 RESULTS 
3.1 Growth of Pchabaudi in Reversed Light 
P.chabaudi grown in mice kept in normal daylight 
shows a synchronous infection with peak schizogony 
occuring at about lam. The antigens studied in this 
project were synthesised late in the erythrocytic cycle 
(Boyle et a) , 1983). Mice were kept in reversed light 
with illumination from 5.30pm to G.30am for at least one 
week before infection with parasites. Under these 
conditions parasites underwent schizogony during the 
day. 
Ratios of the different developmental stages were 
obtained by counting over 200 parasitised cells. After 
schizogony the distribution of parasite stages changed 
from 90-100% trophozoites to 90-1007. rings. This took 
place over 6 hours. Cloned isolates were found to go 
through schizogony at slightly different times. Figure 3 
shows the increase in the proportion of ring stage 
parasites in infections of P..chabaudi isolates AS, CB 
and ER. Counts were done on three separate occasions and 
the graph shows the average of these results. It shows 
ER undergoing schizogony between 7.30am and 1.3Opm, GB 
between 9.30am and 3.30pm and AS between 11am and 
4. 3Opm. 
Figure 3. Graph of X of ring stage parasites in infection of 
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3.2 Monoclonal Antibodies 
3.2.1 Production of Monoclonal Antibodies 
A total of twelve fusions was carried out- Several 
fusions were lost very rapidly due to contamination. 
Other fusions produced cell lines secreting antibody but 
these were lost in the overgrowth of non-secreting cell 
lines- Two fusions, numbers 3 and 12, were successful in 
producing lasting hybrid cell lines. Fusion 3 was with 
spleen cells from a mouse immunised with the 
P.chabaudi line AS. 70% of the wells plated out 
produced HAT resistant cell lines with 60% of these 
secreting antibodies. Fusion 12 was raised against the 
CB line . 86% of wells plated out had HAT resistant cell 
lines with 73% of them secreting antibodies. From these 
two fusions, 17 hybrid cell lines were grown up and 
cloned. The mcabs were given a numerical label 
consisting of the number of the fusion where their cell 
line was produced followed by a number given to an 
independent cell line derived in that fusion eq 12.1 was 
the first line obtained from fusion 12. IFA (2.5.4) was 
used to screen the hybridoma culture supernatants. 
The slight variation in fusion protocols (2.5.2) 
did not make any difference to the specificity of the 
resulting mcabs. P3-X63-NS/1 secretes a light chain 
immunoglobulin intracellularly (Kohler et al , 1976) 
but P3-X63-AgB.653 does not secrete any immunoglobulin 
(Kearney et al , 1979). Both cell lines fused with high 
efficiency 
96 wells were plated out with 0.5m1 aliquots in 
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fusion 3 while in fusion 12, 480 wells were plated out 
with 0..1ml aliquots. The main advantage of plating out 
0.1ml amounts was that nearly all the antibody secreting 
wells contained only one colony. However, all cell lines 
were cloned by limiting dilution (2.5.5) at least once. 
3.2.2 Immunoglobuliri Subclass of Antibodies 
Using the method of double diffusion (2.5.8) the 
immunoglobulin subclasses of the antibodies produced 
were determined. 12.4 was IgG2b, 12.8 was 1q61. All 
other antibodies were IqG2a. 
3.2.3 Patterns of IFA 
Several different IFA patterns were observed with 
mcabs to P.chabaudi - Several antibodies reacted with 
the surface of all red blood cells, both parasitised and 
non-parasitised, and were discarded. One antibody 
reacted with the membranes of red blood cells infected 
with parasites. Some antibodies reacted with only some 
stages of the erythrocytic cycle of the parasite while 
others reacted with all. Within the parasite specific 
antibodies 4 different fluorescent patterns could be 
distinguished. The different fluorescent patterns are 
shown in figure 4 
3.3 Antigen Characterisation 
The proteins with which the mcabs reacted were 
identified by immunoprecipitation (2.4.2) and Western 
blotting (2.6.4). The results are shown in figures 5, 6 
Figure 4. Different patterns .observedd mt IFA. of late 
stage trophozoites and schizonts. 
Type 1 mcabs produced very bright fluorescence with an 
irregular staining pattern. These antibodies reacted 
with late trophozoites and schizonts. 
Type 2 mcab produced a bright staining pattern similar 
to that of type 1. In addition, many other apparently 
smaller parasites also reacted with this antibody. The 
antibody reacted with all stages of the parasite cycle. 
Type 3 mcab produced fluorescence which appeared as 
small clusters of bright dots. This antibody reacted 
with late trophozoites and schizonts. 
Type 4 fluorescence appeared as circles of bright dots, 
this mcab reacted with all stages of the parasite. 
Type 5 fluorescence was a collection of bright spots 
with an associated dull diffuse type of fluorescence. 
This mcab reacted with all stages of the parasite. 
Type 6 pattern was a hazy fluorescence with a few very 
bright spots. This mcab reacted throughout the 
erythrocytic cycle. 
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and 7. The characteristics of the antigens distinguished 
by their WA patterns are as follows.. 
Type 1: The reactivity shown by mcabs 3.7, 3.8, 
3.12, 12.3, 12.4, 12.6, 12..11, 12.12, 12.13, 12.15, 
12.17 and the mcabs of D.Boyle and C.Hamers-Casterman. 
The IFA pattern was very bright fluorescent staining 
over an irregular shape . The antibodies reacted only 
with late stage trophozoites and schizonts. Figure 5 
(Sed. 24Z.2.) 
shows an autoradiograph of metabolically labelled kcB 
parasite extracts immunoprecipitated with mcabs 12.3, 
12.4, 12.11, 12.12, 12.13, 12.15, 12.17 and BE. 
The major band on the gel is a protein of Mr 250 000. 
Figure 6 shows a Western blot of AS and CB parasite 
extracts with 3.7, 3.8 and 3.12. Mcabs 3.7 and 3.12 only 
react with AS while 3.8 reacts with AS and CB. The 
antigen of AS appears slightly larger than that of CE. 
H3 reacts only with the CE 250kDa protein in the Western 
blot shown on figure 7 and not with the protein of AS. 
Type 2: Reactivity shown by mcab 12.16. The WA 
pattern was similar to that of type 1 but also showed 
reaction with all stages of the erythrocytic cycle as 
small bright irregular staining. Figure 5 shows that 
12.16 reacted with the 250kfla protein recognised by Type 
1 mcabs. 
Type 3: Mcab 12.10 had an IFA pattern of clusters 
of brightly staining dots. This antibody reacted with 
the late stages of the parasite in the erythrocytic 
cycle. The Western blot of figure 7, track e, shows 









Figure 5. Autoradiograph of metabolically labelled CD 
parasites immunoprecipita Led by mcabs and run on 7.5% 
SDS--PAGE. Numbers on left are molecular weight markers 
x1O. a, serum from mouse used in fusion; b, 12.3; c, 
12.4; d, 12.11; e, 12.127.; F, 12 	13; g, 12.15; 	h, 	12.16; 
i, 12.17; j, BB. 
OMP - 	- - - -  
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a 	b 	c 	d 	e 	f 	g 	h 
Parasite extracts were also immunoprecipitated with 
normal mouse serum. Pi series of very low intensity bands 
similar to the minor bands on the mcab tracks was 
observed (results not shown). 
Figure 6. Parasite extracts from AS and CB run on 7.5% 
SDS-PAGE and blotted with mcabs.. Numbers on left are 










Blots probed with normal mouse serum identified bands of 
similar molecular weight to the minor bands observed 
with the mcabs (results not shown). 
Figure 7. Parasite extracts from AS and CB run on 107. 
SDS-PAGE and blotted with mcabs. Numbers on left are 
molecular weight markers x10. a, 12.18; b, 12.14; c, 
12.8; d, 12.1; e, 12. 10; f, H3. 
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AS CB AS CB AS CB AS CB AS CB AS CB 
a 	b 	c 	d 	e 	f 
When normal mouse serum was used to blot a track a 
number of bands reacted. The pattern was similar to 
those minor bands observed with the mcabs results not 
shown) 
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Type 4: Mcab 12.8 reaction on lEA showed circles 
of brightly staining dots. This mcab reacted throughout 
the erythrocytic cycle. Figure 7 track c shows 12.8 
reacting with a protein of Mr 90 000 from CB only on the 
Western blot. 
Type 5: On IFA 12.14 showed a reactivity pattern 
of a collection of spots with duller diffuse 
fluorescence associated with the spots. This mcab 
reacted with all of the erythrocytic stages. Figure 7 
track b shows 12.14 reacting with a protein of Mr 110 
000 from both AS and CB, although the AS protein appears 
slightly smaller than that of CR. 
Type 6: Mcab 12.18s reaction in IFA appears as a 
dull fluorescence with a few brightly staining spots. 
This pattern was seen throughout the cycle. Figure 7, 
track a, shows the reaction of 12.18 with a protein of 
Mr 42 000 from AS and CB with the protein of AS 
appearing slightly larger than the CB protein. 
Type 7: Mcab 12.1 reacted with the membranes of 
erythrocytes infected with all erythrocytic stages of 
the parasite. It reacts with a protein of Mr 55 000 on 
AS and CB shown on figure 7, track d. 
The results are summarised in Table 2. 
3.4 Antigenic Diversity of P.chabaudi 
In this section the extent of antigenic diversity 
between a number of cloned isolates of P.chabaudi 	was 
examined using immunofluorescence, immunoprecipitation 
Table 2- Reactivity of Mcabs. 
Mcab Fluorescence Stage Hr of 
pattern specificity antigen 
3.7,3.8,3.12 1 late trophozoites 250kDa 
12.3, 12.4, and schizonts 
12.6, 12.11, 
12. 12, 12. 13, 
12.15, 12.17 
12.16 2 all stages 250kDa 
12.10 3 late trophozoites 210kDa 
and schizonts 
12.8 4 all stages 90kDa 
12.14 5 all stages llOkDa 
12.18 6 all stages 421, Da 
12.1 7 membrane of 55kDa 
infected rbc 
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and Western blotting. 
3.4.1 Antigenic Diversity Identified by IFA 
36 mcabs were available to screen 12 cloned 
isolates. At least two separate antigen preparations 
were made of each clone and they were tested several 
times. Both culture supernatantants and ascitic fluids 
of mcabs produced in this study were used. Culture 
fluids were used undiluted and gave clear positive or 
negative reactions. Most ascitic fluids gave general 
fluorescence when used undiluted or 1/100 dilutions 
similar to that shown by normal mouse serum. Serial 
doubling dilutions of ascitic fluids from 1/1000 were 
tested on the isolates and the last dilution showing 
bright fluorescence was noted as the end point. At 
1/1000 dilutions or less, positive reactions could be 
clearly differentiated from negative reactions. Serial 
dilutions of mcabs from D.Boyle were also tested. 
C.Hamers-Casterman provided serum containing mcabs and 
they were used at 1/500 dilution. Some of the results of 
the titrations are shown in table 3. 
Differences in the brightness of fluorescence were 
observed. These were caused by several factors. Some 
mcabs gave much brighter staining than others. The group 
of mcabs reacting with the 250kDa antigen gave the 
brightest fluorescence. Mid stage trophozoites showed a 
reaction with the mcabs reacting with the 25OkDa antigen 
but the brightness of the reaction increased as the 
parasites matured to schizonts. Thus antigen 
Table 3. Titration of mcabs with AS and GB. Numbers 
indicate the reciprocal of the last dilution showing 
good fluorescence. 
Mcab 	 AS 	 GB 
Be 	 4000 	 4000 
12.15 	 64000 	 64000 
81 	 32000 	 32000 
3.8 	 8000 	 8000 
12.12 	 32000 	 32000 
B2 	 64000 	 - 
83 	 16000 	 - 
12.3 	 - 	 32000 
12.13 	 - 	 64000 
12.16 	 64000 	 64000 
12.18 	 2000 	 2000 
12.8 	 - 	 64000 
12.14 	 8000 	 8000 
12.10 	 4000 	 4000 
12.1 	 >128000 	 >128000 
Table 4. Antigenic Diversity of P.chabaudi Identified by IFA. 
CAR Conan Ca 
Mr of Antigen* AS CD ER AF AJ AL AQ BE CR DK DS EF 
250000 + ± + + + ± + + + + + + 
250000 + + + + + + + 
250000 + + + + + + + + + 
250000 + + ± + + + + + 
250000 + + - - - - - - + - 
250000 + + + + + + + 
250000 + - + + + + + 
250000 ± + -- - - - - - 
?50000 + - - - - - - - + - 
250000 ± + - ± + - 
250000 - + + + + + 
50000 - + -- - - - - - - - - 
250000 - ± ± + + - 
250000 - ± + -- - - - - - - - 
250000 - + + -- - - - - - - - 
90000 - ± + - 
210000 + + + + + + ± + + + + + 
110000 ± + + + . + + + + + + + 
42000 + . + + + + + + + + + + 
55000 . + + + + ± + + + + + + 
Mcab 




















+ = positive 
- negative 
Ca Cameroun 
* Mr varies between isolates, see section 3.4.2. 
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immunoprecipitate the 250kDa protein of AS, GB and OS. 
The precipitates were then digested with staphylococcal 
VS protease. The molecular weight of the antigen 
recognised by the mcab was SkDa less in GB than AS. The 
peptide maps obtained from the digest also showed major 
differences. 
Figure 8 shows size polymorphisms of the 250kDa 
protein in seven cloned isolates of P.chahaucii . The 
isolates were labelled and extracted by two methods 
(2.4.2). AS, AJ, OS and EF were metabolically labelled 
before the erythrocytes were lysed and parasite proteins 
extracted. This resulted in a doublet being precipitated 
by mcab 12.13. The other isolates were freed from host 
cells by saponin lysis before labelling. The 
precipitates had a reduced lower band. This was the 
opposite to that found by Epstein et al (1981). They had 
mcabs to a protein of P.kr,owlesi synthesised in 
trophozoites and schizonts. Parasite proteins were 
metabolically labelled and extracted prior to 
immunoprecipitation by the mcab. If the proteins were 
extracted in Triton X-100, a protein of Mr 250,000 was 
precipitated. However, if the labeled schizont infected 
cells were saponin lysed before Triton X-100 extraction, 
a second protein of Mr 240,000 was also precipitated. 
This suggested that the saponin might activate a 
protease or glycosidase, although all samples also 
contained protease inhibitors. 
Apart from differences in sample preparation, the 
immunoprecipitation shows at least three sizes of the 
Figure S. Autoradiograph of seven isolates metabolically 
labelled and immunoprecipitated with mcab 12.15, run on 
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protein identified by the mcab 12.15 in the clones. In 
AS, AJ and OS, a protein of similar size is 
precipitated. In EF, the protein appears slightly larger 
while in CE', BK and ER it is slightly smaller. 
Figure 7 shows other antigens which also have 
differences in their molecular weights between AS and 
CS. Mcab 12.18 reacts with a protein of Hr 42000. In AS 
the protein is slightly larger than in CS. The antigen 
of Hr 110000 recognised by mcab 12.14 is slightly 
smaller in AS than in CE'.. 
3.5 Genetic Study of Pchabaudi Antigens 
To study the genetic basis of the antigenic 
diversity seen in P.chabaudi isolates, three crosses 
(2.3) were made between antigenically distinct clones. 
Two crosses were made between clones AS and CB which in 
addition to the antigenic markers, differed in their 
response to pyrimethamine and in electrophoretic forms 
of three enzymes 6-phosphogluconate dehydrogenase (POD), 
lactate dehydrogenase (LDH) and adenosine deaminase 
(ADA). The uncloned progeny of these crosses as well as 
25 clones derived from the progeny were examined for 
their reactions with mcabs. The same clones were also 
examined for enzyme and drug-response characters (work 
of F. A.Lainson and D.Walliker). A third cross was made 
between clones AS and ER (work of A.Sharkey). Progeny 
clones of this cross were examined only for their 
antigen characters. 
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3.5.1 IFA Studies on Uncloned Cross Progeny 
Antigen preparations were made of uncloned progeny 
from the crosses and these were used in a double IFA 
test (2.6.1). Figure 9 shows examples of the results. 
9a and 9b show the progeny from an AS/GB cross. 
The progeny were stained with mcab 12.12 (isotype IgG2a) 
and mcab H3 (isotype IgG2b), followed by fluorescein-
(FITC) conjugate specific for IgG2a and rhodamine-
(TRITC) conjugate specific for IgG2b. 12.12 reacts with 
both AS and GB, while H3 reacts only with GB (Table 4). 
Thus in the double WA, parasites stained only with FITG 
have AS-type antigen (1) and those stained with both 
reagents have GB type antigens (2) Table 5 shows the 
proportion of each type of antigen in a sample of the 
uncloned progeny. Approximately equal numbers of each 
type of progeny were observed. No parasites stained only 
with rhodamine were seen. 
9c and 9d show the progeny from the AS/ER cross. 
These progeny were stained with mcab B14 (isotype IgG2a) 
and mcab H3 (isotype IgG2b). This was followed by 
fluorescein-conjugate specific for IgS2a and rhodamine-
conjugate specific for IgG2b. Mcab £414 reacts only with 
AS and H3 reacts only with ER. 9c shows parasites with 
AS-type antigen (3) while 9d shows those with ER-type 
antigen (4). No parasites were found which reacted with 
both fluorescein and rhodamine. Table 5 shows the number 
of each type of progeny in a sample from this study. Two 
antigen preparations of AS/ER progeny were made, one 
being after treatment with 20mg/kg pyrimethamine for 3 
14 6fl ,_k' 
Figure 9. Examples of double label IFA on unci oried cross 
progeny. 
(a) and (b) are the uncloned progeny from the 
AS/CE cross. They were reacted with mcabs 12.12 (IqG2a) 
and 1-43 (IgB2b). (c) and (d) are the uncloned progeny 
from the AS/ER cross. They were reacted with incabs B14 
(IgS2a) and H3 (1g82b). 
Parasites were stained with antiserum to mouse 
Ig2a conjugated to FITC and antiserum to mouse IqG2b 
conjugated to TRITC 
(a) and (c) were photographed under a filter 
which identifies parasites stained with fluorescein. (b) 
and (d) were photographed under a filter which 
identifies parasites stained with rhodamine. 
1 denotes AS/CE parasites stained only with 
fluorescein. 2 denotes AS/CE parasites stained with 
-fluorescein and rhodamine 
3 denotes AS/ER parasites which stain only with 




Table 5. Proportions of antigen types in uncloned cross progeny. AS/ER(pyr) 
are the cross progeny treated with 20mg/kg for 3 days 
Cross 	Total Parasites Total FITC Total 	TRITC Total 	labelled Ratio 
Counted -labelled -labelled with FITC & TRITC A8:CB/ER 
P38/CB 	245 0 113 1 -:12, 54:46 
AS/ER 	134 13 121 0 10:90 
AS/ER(pyr) 	202 41 161 0 20:80 
C 
'.5 
days and the other was without any drug. There is a 
great excess of ER-type progeny in both samples, with 
the drug treatment increasing the proportion of AS-type 
progeny slightly. 
3.5.2 IFA Profiles of Cloned Cross Progeny 
A selection of AS/CB clones shown to be 
recombinant for isoenzymes and pyrimethamine response 
were screened with the mcabs reacting with the 250kDa 
protein and with mcab 12.8 which reacts with a separate 
90kDa protein. The results are shown in table 6. 
The lEA profile of each AS/CB cross progeny clone 
with mcabs recognisng the 250kDa protein was like that 
of either the AS or the CB parent. No parasites reacting 
with tj mcabs for both parents were seen. Progeny 
showing recombinant combinations of 250kDa reactivity 
and reaction with mcab 12.8 were found. Recombinant 
combinations of antigens with isoenzymes and 
pyrimethamine response were also found. 
The IFA profiles for the cloned progeny of the 
AS/ER cross are shown in table 7. As in the AS/CB 
crosses, the WA profiles for the 250k0a protein were 
either AS-type or ER-type. 
3.5. 3 Peptide Mapping of Cloned Cross Progeny 
To study the cross progeny further, the VS 
protease from Staphylococcus aureus was used to digest 
the immunoprecipitates (2.6.3). The results are shown in 
figures 10 and 11. 
Table 6. Characteristics of cloned Proqeny from AS/CB cross. 




814 H10 42 
84 H4 Hi 
812 82 3.12 83 3.7 12.6 143 12.3 12.16 12.13 12.8 LDH ADA PYR 
AS + + + + + - - - - - - 3 6 S 
CS - - - - -. + + + + + + 4 8 R 
AS/C83 + + + + + - - - - - - 3 8 S 
6 + + + + + - - - - - - 3 6 S 
10 + + + 4+ - - - - - + 3 6 R 
12 + + + + + - - - - - + 4 6 S 
13 + + + + + - - - - - - 3 6 S 
15 + + + + + - - - - - - 4 6 S 
26 + + + + + - - - - - - 3 9 5 
52 + + + + + - - - - - + 4 8 n.t 
53 + + 4+ + - - - - - - 3 8 n.t 
55 + + + + + - - - - - + 4 B n.t 
62 + + + + + - - - - - - 3 8 n.t 
63 + + + + + - - - - - - 4 8 n.t 
75 + + + + + - - - - - - 3 8 n.t 
1 - - - - - + + + 4. - 3 8 S 
8 - - - - - + + + + + + 3 9 R 
9 - - - - - + + + + + - 4 8 S 
17- - - - - + + + + + + 4 B S 
18- - - - - + + + + + - 3 8 S 
27- - - - - + + + + + + 3 8 R 
31- - - - - + 4• + + + - 3 6 S 
34- - - - - + + + + + + 4 8 S 
36- - - - - + + 4. + + - 4 8 S 
56 - - - - - + + + + + + 4 B n.t 
57 - - - - - + + + + + + 4 8 n.t 
64 - - - - - + + + + + + 3 8 n.t 
Reaction with mcabs, + is positive, - is negative. 
LDH - Lactate dehydroqenase, numbers are electrophoretic mobilities. 
ADA - Adenosine deaminase, numbers are electrophoretic mobilities. 
PYR - Pyrimethamine response, R is resistant, S is sensitive. 
n.t. - not tested 
Table 7..IFA profile of cloned progeny from AS/ER cross. 
81 3.8 812 82 3.12 816 83 3.7 H3 12.3 12.16 
AS + + + + + + + + - - - 
ER - - - - - - - - + + + 
AS/ER1 + + + + + + + + - - - 
B + + + + + + + + - - - 
14 + + + + + + + + - - - 
12 + + + + + + + + - - - 
27 + + + + + + + + - - - 
39 ± + + + + + + + - - - 
3 - - - - - - - - + + + 
5 - - - - - - - - + + + 
6 - - - - - - - - + + + 
7 - - - - - - - - + + + 
11 - - - - - - - - + + + 
13 - - -. - - - - - + + + 
15 - - - - - - - - + + + 
17 - - - - - - - - + + ± 
21 - - - - - - - - + + + 
24 - - - - - - - - + + + 
28 - - - - - - - - + + + 
30 - - - - - - - - + + + 
32 - - - - - - - - + + + 
42 - - - - - - - - + + + 
44 - - - - - - - - + + + 
51 - - - - - - - - + + + 
53 - - - - - - - - + + + 
54 - - - - - - - - + + + 
55 - - - - - - - - + + + 
57 - - - - - - - + + + 
61 - - - - - - - - + + + 
62 - - - - - - - - + + + 
63 - - - - - - - - + + + 
64 - - - - - - - - + + + 
65 - - - - - - - - + + + 
66 - - - - - - - - + + + 
.7 
Figure 10 shows AS, GB and the progeny of their 
cross. Due to loading unequal counts on the gels, they 
were exposed two times and the figure is a compilation 
from the two exposures. Differences were seen in the 
peptide fragments of the two parents after digestion by 
the protease. The peptide maps of the cross progeny 
appeared largely similar to the maps obtained with 
either AS or CS. However, AS/GB B shows some unique 
minor bands, indicated by *. 
Figure 11 shows AS/ER cross progeny and the 
parents of the cross. The peptide maps of the cross 
progeny after digestion were exactly the same as that of 
AS or ER. 
The similarity of a peptide map of the cross 
progeny to a parental peptide pattern was related to the 
similarity of the IFA profiles shown in tables 6 and 7. 
Figure 10. Metabolically labelled AS, CB and cloned AS/CB 
progeny immunoprecipitated with mcab 12.15 and digested 
with protease. Samples were run on 12.57. SDS-PA6E. 
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Before protease, 0; after 1mm, 1; after Smins, 5; after 
30mins, 30. Tracks are in the same order on all gels. a, 
AS; b, AS/CB 10; c, AS/CB 15; d, AS/CB 34; e, AS/CB 1; f, 
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Figure 11 Metabolically labelled AS, ER and cloned AS/ER 
progeny immunoprecipitated with mcab 12.15 and digested 
with protease. Samples were run on 12.57. SDS-PAGE. 
Numbers on left are molecular weight markers x1O. 
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Before protease, 0; after 1mm; 1; after Smins, 5; after 
30mins, 30. Tracks are in the same order in all gels. a, 
AS; b, AS/ER 7; c, AS/ER 19; d, AS/ER B; e, AS/ER 20; f, 
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4 DISCUSSION 
The topics discussed in this chapter have beer 
divided into sections and follow a similar order to the 
results chapter.. The first section deals with the 
production of mcabs including the choice of myeloma, 
feeder cells and also discusses the choice of B-cells. 
In the second section the characterisation of the 
antigens with which the mcabs react is discussed, in 
relation to possible equivalent antigens in other 
species of Plasmodium . Section three surveys antigens 
which have been identified by mcabs and implicated in 
the protective response of the host.. The fourth section 
discusses diversity of some of the antiqens mentioned in 
section three which induce a protective response. The 
fifth section discusses the genetics of the antigens of 
malaria parasites. The final section includes general 
conclusions with regard to this study. 
4.,1 Production of Monoclonal Antibodies 
Since the first generation of mcabs by Kohler & 
Milstein (1975), the technique has been used widely with 
many subsequent modifications. The basis of the 
technique is the fusion of spleen cells from immunised 
mice with murine plasmacytoma cells. Although the 
original fusing agent was Sendai virus, many groups now 
use polyethelene glycol (PEG). This procedure results in 
a mixture of fused and unf used cells. It is necessary to 
eliminate unfused tumour cells and tumour-tumour hybrids 
leaving the tumour-spleen cell hybrid which will secrete 
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antibody of the desired specificity. Unfused spleen 
cells cannot survive in culture so fusion with the 
tumour cell line confers immortality on the antibody 
secreting cell. 
Selective elimination of tumour cells is achieved 
by using a cell line deficient in the enzyme 
hypoxanthine phosphoribosyl transf erase (HPRT) which 
is responsible for the incorporation of hypoxanthine 
into DNA. Fused cells are grown in medium containing 
hypoxanthine. aminopterin and thymidine (HAT) 
(Littlefield, 1964). Aminopterin blocks 'de novo" 
synthesis of DNA, and to grow in this medium cells must 
make DNA via the "salvage" pathway using hypoxanthine 
and thymidine. The only cells which will grow in HAT 
medium are the hybrids formed when the tumour cells fuse 
to the spleen cells. The spleen cell provides the HPRT 
enzyme and the tumour cell provides immortality. 
The plasmacytoma cell line which Kohler and 
Milstein used in their original fusions was P3-X63-AgB 
which had the disadvantage that it secreted 
immunoglobulin itself and so hybrid cells secreted 
myeloma antibody and desired antibody. The mixture of 
antibodies may lower the titre of the desired antibody. 
The myeloma cell lines used in this project were derived 
from this cell line. P3-X63-AgB-NS1 was selected by 
Kohler et al (1976). Although it synthesises a light 
chain antibody, it is not secreted- P3-X63-AgB.653 does 
not synthesis any immunoglobulin and was developed by 
Kearney et al (1979). 
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In initiating new culture lines, in plating out 
fused cells, and growing cells at very low densities it 
is advisable to add extra cells to provide supplementary 
growth factors and increase cell density. In this study 
three different types of feeder cells were used. Normal 
spleen cell were used when plating out newly fused 
cells, and thymocytes and peritoneal exudate cells were 
used for cloning. No controlled comparisons between the 
different cell types were carried out but all three 
fulfilled their function. The main disadvantage with 
using thymocytes is that the donor mice have to be less 
than six weeks old because the thymus decreases in size 
after that age- Spleen cells contain a large number of 
red blood cells which can hinder examination of the 
cells through the microscope. Care must be taken when 
obtaining peritoneal exudate cells not to pierce the 
intestine. Samples of cells should always be incubated 
for 24hr5 before use to ensure they are not 
contaminated. Other cell lines can be used, such as rat 
thymocytes, which give a much higher yield than mouse 
thymocytes. Another alternative is conditioned medium, 
which is medium from cultures which contains growth 
factors but has been centrifuged to remove the cells. 
Apart from the choice of myeloma cell line there 
is also the choice of cells with which to fuse them. The 
majority of mcabs to malaria have been made using spleen 
cells from mice immunised with parasites or their 
extracts. Deans et al (1982) immunised a rat with 
P.kr,ow1esi and fused the rat spleen cells to produce 
mcabs. 
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Stanley and Reese (1985) took a spleen from a 
monkey which was immune to Pfalciparum and fused it 
with the mouse myeloma cell line P3-X63-Aq8.653. The 
monkey-mouse system had an efficiency equal to that of 
the mouse-mouse system. Their reason for using the 
monkey spleen was that epitopes seen by a primate should 
be more relevant to the production of human immunity 
than structures seen by a rodent, which cannot 
experience the disease. 
Several groups have recently produced human mcabs. 
Schmidt-Uilrich et al (1986) isolated peripheral blood 
lymphocytes (PBL) from Gambian adults who were immune to 
P.faiciparum malaria. The PBLs were cultured for seven 
days in the presence of pokeweed mitogen and then fused 
with PEG to a human lymphoblastoid line. 4 mcabs were 
found which could inhibit parasite growth in vitro . 3 
of these mcabs precipitated a parasite protein of Mr 195 
000. A different method for producing human mcabs was 
used by Brown et a) (1986). They isolated mononuclear 
cells from Gambian adults who had low grade 
P.falciparum infections. The mononuclear cells were 
infected with Epstein-Barr virus. Culture supernatants 
were found to be able to inhibit in vitro growth of 
P.falciparuni . Unfortunately there were no lasting 
cultures due to contamination or the surviving cells 
stopped producing anti-malarial antibodies. 
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4.2 Antinen Identification 
Before the advent of mcabs, immune serum was used 
to study antigens of malaria. These sera showed a great 
deal of cross reactivity between species, for example 
El-Nahal (1967) was unable to distinguish P.yoelii 
from P.berghei or P.vinckei from P.chabaudi by lEA 
using antisera raised against each species. Human serum 
raised against P.falciparuw or P.vivax reacted with 
both species on IFA (Diggs and Sadun, 1965). 
Immune serum used in 	IFA reactions gives 
fluorescence on all parasites. The use of mcabs in IFA 
shows different patterns and can also identify stage 
specific antigens. In this study 11 mcabs were produced 
which gave a similar fluorescence pattern with late 
stage parasites. This was the same pattern obtained by 
Boyle et al (1982) for their mcabs, some of which 
inhibited parasite growth. A similar pattern was also 
found by Holder et al (1981) for a mcab raised against 
P.yoeiii . When the antigen with which this mcab 
reacted was purified and used to immunise mice it was 
found to induce a protective response. Hall et al 
(1984a) also used a mcab, giving a similar IFA pattern 
with P. -falciparum , to purify the protein. They 
immunised monkeys with it and found that it induced some 
protection. 
Using immunaprecipitation and Western blotting, thefl 
P.chabaudi mcabs were found to react with a protein of 
Mr 250OQ. Other minor bands were also seen. These are 
probably the result of protein processing which has been 
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characterised in 	P.falciparum 	(Holder and Freeman, 
1982) and P.yoelii (Holder and Freeman, 1984). The 
proteins were metabolically labelled when most of the 
parasites were at the the late trophozoite stage but 
because the infection is not precisely synchronous, some 
of the parasites would be undergoing schizogony. Some 
processing would be taking place despite the presence of 
protease inhibitors. 
The results of the Western blots (figure 7) do not 
appear as clean as the immunoprecipitations (figure 5). 
Many bands were common to all mcabs and were thought to 
be non-specific. The band with which each mcab 
specifically reacted is arrowed next to the track 
(figure 7). The specific bands generally developed first 
with the others appearing after a few minutes. 
The other mcabs produced in this study were 
selected because they produced different fluorescent 
patterns when the supernatants from their primary wells 
were tested. The results from the Western blotting 
showed that they all reacted with different antigens. 
The exception to this was 12.16 which also reacted with 
the 250kDa protein. This mcab reacted throughout the 
erythrocytic cycle so probably reacts with an epitope 
which is on the part of the protein conserved on 
reinvasion. Hall et al (1984b) showed that the 
equivalent protein of P.falciparum was synthesised by 
trophozoites and schizonts. An epitope of this protein 
identified by a mcab was lost during release and 
reinvasion of merozoites. Another mcab recognised a 
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different epitope on this protein, and this was found to 
survive reinvasion. 
The antigens with which the mcabs react can be 
characterised by size, IFA pattern and stage 
specificity, but their function is unknown at present. 
Oko et al (1984) studied a P.yoelii mcab with a 
dotty fluorescent pattern by immunoelectron microscopy. 
They found that the incab reacted with the rhoptries. A 
similar punctate double dot fluorescence was also 
observed by two groups studying P.falciparum (Howard 
et al , 1984 and Schofield et al , 1985). They found 
their mcabs precipitated parasite proteins of Mr 82000 
and 80000 respectively. The same antigen is probably 
involved in these two studies, the difference in 
molecular weights probably being due to experimental 
conditions in the two laboratories. This differs 
considerably from the rhoptry protein of P. yoelii 
which has an Mr of 235 000. One of the mcabs produced in 
this study, which produces dotty fluorescence, could be 
reacting with the P.chahaudi rhoptries. However it is 
not possible to determine this by IFA, and 
immunoelectron microscopy would be needed to study the 
antigen's cellular location. 
The use of fixed preparations in lEA exposes many 
more antigens than are exposed on the intact living 
parasite. Mcab 12.1 appears to react with the surface of 
infected erythrocytes throughout the cycle, although its 
reactivity with intact, unfixed parasitised cells needs 
to be studied to confirm this. The reaction of this mcab 
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through the cycle indicates it is unlikely to be related 
to an antigen present in the membrane of ring infected 
erythrocytes of P.chahaudi described by Gabriel et 
al , (1984). 
4.3 Protective Antigens Identified By Mcabs 
Mcabs can be used to identify antigens which are 
involved in inducing a protective response by the host 
in two ways. The first is to study the effect of the 
antibodies on the course of infection. The second is to 
use the mcab to purify the antigen which is then used to 
immunise an animal. The effect of immunization is 
measured by challenging the animal with a dose of viable 
parasites. In both cases results are compared to 
controls. 
Freeman et al 	(1980) tested serum from mice 
bearing hybridoma tumours for their ability to control a 
virulent line of P.yoelii . They found some which 
reduced the parasitaemia to the levels of a nonvirulent 
line. The mcabs were used to purify the antigens with 
which they reacted (Holder and Freeman, 1981). A 
purified antigen, Mr 235000, was found to protect mice 
against infection. Another mcab, which had not been 
effective when given to mice directly, was used to 
purify the protein with which it reacted. When the 
purified protein, Mr 230000, was used to immunize mice, 
they survived challenge. Playfair et al (1985) 
correlated the protection obtained, with T-cell mediated 
immunity. 
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Of eleven mcabs reacting with a 250kDa protein of 
P.chabaudi , Boyle et a.! (1982) tested four and found 
two which could delay the rise in parasitaemia and 
reduce its peak. When given together, the effect was 
slightly greater indicating a synergistic effect. These 
mcabs, Si and 53, have been shown in this study to react 
with different epitopes. If the protein of P.chabaudi 
undergoes processing to smaller fragments on the surface 
of the merozoite like its counterpart in P.yoelii 
(Holder and Freeman, 1984), then these epitopes involved 
in inducing some immunity, might be on the merozoite 
surface. They would then be exposed to antibody attack 
when the inerozoites are released from the red cells. 
Mcab 58 which is common to all isolates tested was 
used to purify the 250k0a protein from AS parasites by 
Brown et al (1985). The purified • protein was used to 
immunize mice. The mice were challenged with AS or CS 
parasites. Challenge with CB parasites showed very 
little difference between immunized and control groups. 
After AS challenge the parasitaemia was delayed and 
reduced in peak. 
Testing the effect of mcabs 	in 	viva 	is 
relatively easy with rodent malarias. However, because 
of the shortage of primates, experiments with simian and 
human malarias have mainly been done in vitro. Epstein 
et al (1981) produced mcabs against a 250kOa antigen 
on the surface of 	P.knowiesi 	merozoites. 	Free 
merozoites and mature sçhizonts of 	P.kr,owiesi 	were 
incubated for two hours with the mcabs. Signs of 
63 
merozoite agglutination were looked for. The mcabs were 
also incubated with mature schizonts and uninfected 
erythrocytes. The mcabs which caused the greatest amount 
of merozoite agglutination also caused the most 
inhibition of invasion. With mcabs to a different 
P.kr,owlesi antigen, Mr 140kDa, Miller €t al (1984) 
incubated mature schizonts and free merozoites prior to 
culture with ascitic fluid. They found that the mcabs 
only affected invasion when incubated with mature 
schizonts. This effect was caused by agglutinating 
merozoites as they were released from erythrocytes, not 
by blocking the merozoite receptors for erythrocytes. 
A mcab raised against P..falciparum was used to 
purify the protein with which it reacted by Hall et al 
(1984a). The mcab reacted against an antigen, Hr 190kDa, 
synthesised late in the erythrocytic cycle of 
P..falciparum . The purified protein was then used to 
immunize three monkeys. Two of the monkeys were able to 
recover from what is normally a lethal challenge. 
Culture fluids of synchronous 	P.falciparum 
cultures were supplemented with lOX ascitic 	fluid 
containing mcabs by Perrin et a) (1981b). The level of 
parasitaemia Was measured by counting Giemsa stained 
smears. The incorporation of H hypoxanthine over a 
14hr period was also measured. They found the rate of 
incorporation of radioactivity paralleled the level of 
parasitaemia. The mcabs showed a range of 	growth 
inhibition. One mcab inhibited growth 100% while others 
were less effective. Schofield 	et a) 	(1982) found 
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growth inhibition levels of up to 40% when they added 
mcab to synchronous cultures of Pfalciparum at the 
schizont stage. They assessed parasitaemias by counting 
parasites and also by flow cytofluorometry with a dye 
which stains DNA. There was no inhibition of parasites 
which were negative with the mcab on IFA. A second batch 
of mcabs made by Schofield et al (1985) included two 
which could inhibit growth in vitro . The inhibition 
was concentration-dependent with 100% inhibition 
obtained with 40ug/ml for one mcab and 250ug/ml for the 
other. 
The human mcabs made by Brown et al 	(1986) and 
Schmidt- Ullrich et al 	(1986) both included mcabs 
which could ii\hibit Pialciparam growth in vitro - 
The above are tests to study mcabs affecting the 
erythrocytic stages of malaria. Mcabs have also been 
made against sporozoites and gametes. Yoshida et al 
(1980) made mcabs against P.berqhei sporozoites. The 
sporozoites were incubated with antibody for 30mins 
before being injected into mice. The mice did not 
develop parasitaemias although control mice developed 
lethal infections. Cochrane et al 	(1982) made mcabs 
against sporozoites of 	P.kr,owlesi . When sporozoites 
were incubated with mcab before injection into rhesus 
monkeys their infectivity was also abolished. Mcabs to 
the sporozoites of the human malarias P.fa1ciparum and 
P..vivax were made by Nardin 	et al 	(1982). These 
mcabs were incubated with sporozoites prior to injection 
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into splenectomised chimpanzees. The mcabs were able to 
delay the onset of patency of infection. 
The mcabs to P.herghei sporozoites (Yoshida 	et 
a.! , 1980) which were inhibitory in vivo 	were also 
shown to be inhibitory in vitro - This was shown by 
their ability to block entry of the sporozoites into 
cultured embryonic lung cells (Hol,lingdale et al, 1982). 
A similar its vitro correlation of the in vivo 
inhibitory effect of mcabs to 	P..falciparum 	and 
P.vivax 	(Nardin 	et al , 	1982) 	was 	shown 	by 
}-Iollingdale 	et al 	(1984). The 	sporozoites 	were 
prevented from invading cultured human hepatoma cells. 
This in vitro test was also-used to study the 
inhibitory effect of mouse and rabbit sera raised 
against a synthetic peptide (Zavala et al , 1985 and 
l3ailou 	et al , 1985). The peptide 	encoded 	the 
immunodominant epitope of the surface protein 	of 
P.falciparum sporozoites 
'Rener 	et al 	(1983) mixed a suspension of 
P..ialciparum gametes, erythrocytes and human serum 
with anti-gamete mcabs and allowed mosquitoes to feed on 
the mixture through membranes. B to 9 days after the 
feed, the mosquitoes were dissected and their midguts 
examined for oocysts. Two mcabs acted synergistically to 
suppress infectivity. Harte et al (1985) produced 
mcabs against the gametes of 	P.yoelii - They found 
antibodies which could agglutinate microgametes 	in 
vitro - They also infected mice, and three days later 
injected the mice with mcab prior to allowing mosquitoes 
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to feed on them. One week after feeding, the mosquitoes 
were dissected and their midguts examined for oocysts. 
These authors, like Rener et al (1983), found two 
mcabs which 	reacted 	synergistically 	to 	block 
transmission of the parasites to the mosquitoes. 
It is difficult to extrapolate the results from 
in vitro inhibition tests and the results with animal 
models to that of human mal an as in endemic areas. 
Naturally occuring infections of Pfalciparum have 
been shown to consist of mixtures of parasites (Rosario, 
1981 and Fenton et al , 1985). Although no deliberate 
selection was employed, Fenton et al (1985) showed 
that the frequencies of the different parasite genotypes 
in the mixture altered over a period of culture. In the 
laboratory it is advisable to use cloned material so 
that the effects on the parasites are clearly seen 
instead of selecting a sub-population. The 
identification of antigens as potential vaccines is the 
beginning of a number of phases, including preclinical 
studies and vaccine trials, which must be passed before 
a vaccine will be in use (WHO, 1986). 
4.4 Antiqenic Diversity Identified By Mcabs 
	
The introduction of a vaccine will 	expose 
parasites to a selection pressure which could lead to 
the selection of antigen types against which the vaccine 
is not effective, or to the appearance of new antigenic 
types. It is thus important to examine the extent of 
antigenic diversity within 	the population 	before 
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vaccines are used.Very few of the studies to identify 
antigens which induce a protective response have 
involved tests of antibodies with different isolates to 
find out if they react with variable proteins. 
Using a battery of mcabs raised against two 
isolates of P.,ialciparum , 1<1 and P81, from Thailand, 
McBride et al (1982) screened 27 isolates from 
different parts of the world. They found considerable 
serological diversity. The isolates in this study had 
been grown in laboratory cultures for some time.. 
However, antigenic diversity was also observed when 
freshly isolated samples of parasites were screened 
(McBride et al , 1984, Knowles et al , 1984 & Howard 
et al , 1986). In the study of Knowles et al (1984), 
antigenic diversity of isolates in PNG was examined. 
They found that the population of P.falciparum in the 
region of Madang to be antigenically heterogeneous. Most 
of the mcabs in these studies were against a 190kDa 
antigen (Hall et al • 1983). This protein was shown to 
induce some protection against P..falciparum in monkeys 
(Hall et al , 1984a). 
An extended panel of mcabs to this 190kDa antigen 
were used by McBride et al (1985) to further 
characterise the antigen. Some mcabs reacted with every 
isolate tested showing that the 190kDa antigens of all 
the isolates are related. Other mcabs recognised 
restricted determinants. Using the mcabs against the 
restricted determinants, isolates could be characterised 
into one of seven serotypes. These serotypes were 
thought possibly to identify alleles of the gene for 
this protein. The DNA sequences of this gene from a few 
isolates were compared and showed areas of extensive 
homology and areas with low homology (Mackay et al 
1985, Tanabe et al , 1986). However it is not known 
which regions of the gene sequence encode the epitopes 
recognised by the mcabs. 
In this study 12 cloned isolates of 	Pchabaudi 
were used to screen for antigenic diversity. B of the 
isolates came from the Central African Republic, 6 of 
them having been isolated in 1969. 30 mcabs reacted with 
the 250kDà protein. These could be divided into 14 
groups on the basis of common reactivity. Each isolate 
could be distinguished by ifG reaction profile with 
the battery of mcabs including the isolates which had 
been collected at the same time. If these serotypes are 
identifying the different alleles of the gene, there are 
at least twelve allel(eist in the P.chahaudi population. 
There did not appear to be any relationship between the 
origin of the isolates and the number of reactive groups 
they had in common. 5 of the mcabs reacting with this 
protein reacted with all the isolates. 4 mcabs, 12.18, 
12.14, 12.10 and 12.1 which reacted with different 
proteins also reacted with all the isolates in the 
sample. Only one of each reactivity was cloned. Several 
would be required to determine whether the whole protein 
or only part of it is constant in all isolates. 
One of the mcabs made by Perrin 	et al 	(1981b) 
which caused inhibition of growth of the erythrocytic 
M. 
stages of P.falciparum was raised aqainst the rodent 
malaria Pberqhei so is likely to cross react widely. 
Schofield et al (1982), raised mcabs to two 
isolates FCQ-27 and FCO-30, from Papua New Guinea (PNG). 
Their mcabs showed diversity between 7 isolates from 
PNG, K1 from Thailand, NF7 from Ghana, W/L from Nigeria 
and NF36 from the Netherlands. No diversity was observed 
within the isolates from PNG. The reason may be due to 
the antigens which the mcabs in these studies react 
with. One of the mcabs was against an S-antigen (Saul 
et al , 1985). The DNA squences of the S-antigens from 
FC27 and NF7 are homologous for most of their lengths 
and the nonhomoloqous regions are comprised entirely of 
tandem repeating units (Cowman et al , 1985). It is 
likely that the epitope with which the mcabs reacted was 
in the region containing tandem repeats. 
Schofield et al (1985) also produced four mcabs 
against the rhoptry protein of Pialciparuw . Two could 
inhibit growth of the PNG isolate the were raised 
against. One of these gave positive reactions on lEA 
with 106 primary isolates from PNG, Thailand and Brazil. 
The other inhibitory mcab gave positive reactions with 
32 of 46 isolates from Brazil. 
The mcabs made against P..kr,onlesi sporozoites by 
Cochrane et al (1982) were not tested against other 
lines of P.knowlesi . However, three were found to 
react with P.cynomolgi and one reacted with 
P.1'a1ciparum . The immunodominant epitope 	of 	the 
sporozoite circumsporozoite protein, encoded by a small 
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synthetic 	peptide, 	is 	present 	in 	strains 	of 
P.falciparum from all over the world (Zavala et al 
1985). The inhibitory mcabs to gametes of P.ialciparum 
made by Rener et al (1983) are also likely to react 
with many isolates. A mixture of isolates was used . to 
immunize the mice before the fusion. A West African 
isolate, not in the mixture, was used to screen the 
primary hybridoma supernatants and a Brazilian isolate 
was used in the inhibition test. 
Each mcab reacts with a specific site known as an 
epitope. It is made up of a small number of amino acids. 
These need not be next to each other on the primary 
protein structure but may be brought together in the 
tertiary structure. Epitopes of this type have been 
shown in lysozyme (Smith-Gill et al , 1982) and 
myoglobin (East et al , 1982). The few epitopes that 
have been identified in malaria proteins have been those 
where the amino acids are close to each other on the 
primary structure. Zavala et al (1985) showed that the 
epitope on the circumsporozoite protein of 
P.ialciparum is contained within a sequence of 4 amino 
acids repeated 3 times. This sequence has homology with 
part of the amino acid sequence of an antigen present in 
the blood stages of the parasite (Hope et al , 1985). A 
mcab reacts with this antigen in schizonts but also 
reacts with sporozoites indicating that this is the 
epitope recognised by the mcab. Hall et al (1984b) 
showed that a polymorphic epitope of the 190kDa protein 
is encoded in the amino acid sequence by translating 
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mRNA in a cell free system. The product from this 
reacted with the mcab. Antibodies can also recognise 
sugar residues on glycoproteins of malaria (Ramasamy et 
al ,1986), This could be important when screening 
recombinant DNA libraries since bacterial systems do not 
produce proteins with the appropriate side chains. 
4.5 Genetic Study of Pchabaudi Antigens 
Diversity within populations usually arises as 
mutations which spread through the population when 
recombination occurs. Previous genetic studies with 
malaria had shown how markers such as isoenzymes and 
pyrimethamine response were inherited in a Mendelian 
fashion (Walliker et a! , 1975). Pyrimethamine response 
was inherited independently of isoenzymes. Resistance to 
chloroquine could also be passed on to sensitive 
parasites during a cross (Padua, 1981). 
The importance of genetic studies on antigens is 
that they identify unequivocally whether variant forms 
are due to allelic variation of a single gene, or 
whether genes at different loci are involved. Alleles of 
a single gene are identified by the fact that they 
segregate at meiosis. This can only be shown by crossing 
experiments. Genes which segregate with high frequency 
from oneanother are on separate chromosomes and are 
unlinked. Genes on the same chromosome are linked and 
segregate from oneanother at very low frequency. 
The purpose of this work was to see if the 
different forms of the 250kDa protein segregated during 
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post-fusion meiosis thereby identifying them as alleles. 
The use of several markers on the one gene, also gave 
the possibility of identifying crossovers occurinci 
within the gene. A crossover between mcab epitopes would 
lead to new combinations of mcab reactivity. 
4.5.1. Alle1jc_Yrjtion of the 250kDa Anjgen 
A large amount of naturally occuring antigenic 
diversity identified by mcabs was found in the twelve 
isolates of Pchabaudi examined in this study. Each 
isolate could havca different reaction profile with the 
mcabs against the 250kDa antigen. These different forms 
were thought to be alleles of the one gene. In order to 
demonstrate if these different forms of the gene would 
segregate after pairing, a genetic cross was performed 
between the AS and GB isolates. Mcabs to the 250kDa 
protein identified 14 epitopes. 10 of these were 
different for their reactivity with AS and GB. 
The profile of reactions of the AS/GB progeny 
clones with the anti-250kDa mcabs was like that of the 
AS or GB parent. No new combinations appeared indicating 
that the epitopes are very closely linked, probably 
within the one gene. The two forms of the 250kDa antigen 
seen in AS and GB can thus be concluded to be allelic. 
Similar results were also found when progeny from 
a cross between AS and ER were examined. There were 11 
mcabs identifying differences between AS and ER. The 
antigen profiles of the cross progeny clones were like 
one or other of the parents of the cross. The forms of 
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the 250kDa antigen on AS and ER are thus also allelic. 
Although all the combinations of isolates would have to 
be crossed to demonstrate that there are at least twelve 
alleles of this gene, the results so far indicate 
strongly that the serotyping of isolates recognises 
alleles. 
The reactivity of all isolates and cross progeny 
with some mcabs showed that the alleles had some common 
regions. To study the structure of these allelic 
proteins further, a method for obtaining peptide 
fragments was used. Cleveland et al (1977) developed a 
method for eluting proteins from gels after 
electrophoresis, digesting the proteins with a protease 
and running the resulting peptide fragments on another 
gel. Newbold et al (1984), modified the technique to 
digest the protein immunoprecipitated by a mcab which 
reacts with a common epitope. The Saureus VS protease 
used in this work cleaves proteins at the carboxyl 
terminal side of aspartic and glutamic acid (Houmard and 
Drapeau, 1972). 
The digestion of the proteins was stopped at 
various time points and the fragments obtained separated 
by 5DB-PAGE and visualised by 4 luorography. The peptide 
maps obtained after the digest of the isolates AS, CB 
and ER showed some peptides with similar mobility but 
many bands were different. The antigen showed structural 
heterogeneity as well as heterogeniety of reactions with 
the mcabs. The peptide maps obtained from the AS/CE 
cloned progeny was similar to that obtained with AS or 
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GB. The As/ER progeny had maps like the AS or ER parent. 
The protein thus appeared to be inherited as a complete 
unit. The similarity of results obtained with a cross 
progeny to those for a parent was the same for the 
peptide digests and for the mcabs IFA profiles. 
A minor exception to this was shown by the peptide 
digest of cross progeny AS/GB B (figure 10). A few 
unique minor bands were seen in the digest after 1 
minute. Although the tracks had unequal amounts of 
radioactivity loaded these bands were seen on a repeat 
of the experiment. A further repeat with equal counts 
should be done so that a proper comparison could be 
carried out. The protease cuts at specific sites on the 
protein. A crossover within the gene could alter the 
number of amino acids between cutting sites causing 
different sized peptides. A change in glycosylation 
could also affect the mobility of peptide fragments. 
It is not known where the epitopes recognised by 
the mcabs are situated on the protein. They may be 
spread along its length or clustered on part of the 
protein. There were 10 mcabs showing differences between 
AS and GB and 11 mcabs showing differences between AS 
and ER. If the markers were on one gene then 
recombination between these markers would be a very rare 
event. None was observed in the progeny from the two 
crosses examined. However during an infection parasites 
occur in the very large numbers which would be the 
appropriate conditions for new combinations of markers 
to arise to give new allelic forms of the antigen. New 
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alleles could also arise as a result of a mutation of a 
molecule in the DNA affecting the amino acid sequence of 
the protein. Any future vaccine must recognise a common 
epitope to reduce the chances of selecting a parasite 
population which will not respond to it. If selected, 
this antigen would probably spread rapidly through the 
parasite population. 
4.5.2. Antgns at Different Loci 
A different antigen, recognised by mcab 12.8 
reacted with GB but not AS. The cloned progeny from the 
AS/GB cross were also tested for their reactivity with 
this mcab.tinlinked markers segregate with a frequency of 
507.. Many of the progeny clones examined showed 
recombination between their 2501,Da profile and their 
reaction with mcab 12.8 indicating that there was no 
linkage between these genes. Both genes also segregated 
independently of the isoenryme markers and pyrimethamine 
response. 
Previous work on the inheritance of antigens was 
by Panton et a! (1984), who studied the inheritance 
Pattern of an antigen of P.yoelii identified by 
crossed-immunoelectrophoresis. The quantity and 
electrophotectic mobility of this antigen varied between 
two lines. The two lines of parasites also differed in 
their virulence. The results of a cross between the two 
lines showed that the quantity of the antigen was 
correlated with the virulence of the parasite. The 
electrophoretic mobility of the antigen 	segregated 
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independently of the virulence- The 	antigen 	also 
seqreqated independently of isoenzyme and drug response. 
4..5.3. Frequency of Genotypes in the Crosses 
The parental lines were transmitted 	through 
moquitoes independently at the time of the cross. When 
the number of oucysts in the midguts of mosquitoes 
infected with the parents were compared, approximately 
equal numbers of 45 and GB oocysts were found. Many more 
oocyst were found on the midguts of mosquitoes infected 
with ER than the AS infected mosquitoes (D..Walliker, 
personal communication). The ability of ER to be 
transmitted through mosquitoes at a higher frequency 
than 45 is reflected in the observation that many more 
ER type progeny were found in the uncloned progeny of 
the cross. Also an excess number of ER type progeny were 
obtained from the cloning. Almost equal numbers of AS 
and GB progeny were found in the uncloned progeny from 
that cross. 
The reasons why ER is transmitted through 
mosquitoes more efficiently than AS is not known. In the 
erythrocytic stages in mice, the time of going through 
schizogony could affect the proportion of parasites in a 
mixed infection. The results of section 3.1 showed AS 
parasites undergoing schizogony after ER parasites. The 
proportions of each type of progeny in the uncloned 
cross progeny (section 3.5.1.) were counted one passage 
but several cycles of infection and reinvasion after the 
sporozoite induced infection. The proportions could 
change if counts were taken in later passages. 
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4.6. General Conclusions 
The use of mcabs has enabled individual antigens 
to be studied. These mcabs have identified variant 
antigens between different isolates of the rodent 
malaria species P.chabaudi 
Each isolate had a distinct reactivity profile 
with the mcabs. 
The mcabs have not established any geographical 
basis for the antigenic diversity. 
Mcabs with similar IFA staining pattern reacted 
with an antigen of the same molecular weight. 
Mcabs which had different JFA staining patterns 
were found to react with antigens of different molecular 
weights. 
When two crosses were carried out between 
isolates, the antigen profiles of the cross progeny were 
like 	one 	or 	other 	of the 	parents. 	No 	recombinant 
profiles were found. 
The peptide maps resulting from digestion 	of the 
immunoprecipitation 	of cloned progeny 	of 	the 	cross 
appeared like the maps obtained for one or other of the 
parents. The relatedness to the parent was the 	same as 
the antigen profiles. 
The 250kDa antigen appears to be 	the 	product of 
one gene which has many alleles. 
The gene for the 25OkDa protein 	appears 	to be 
inherited independently from the gene 	coding 	for the 
90kDa protein recognised by mcab 12.8. 
IN 
Bath antigen genes are inherited independently 
from the isoenzymes and pyrimethamine response used as 
other genetic markers. 
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A 250 Is Da antigen implicated in the induction of protective immunity 10 Plasmodium chabaudi was 
examined with a panel of II monoclonal antibodies in cloned parasite lines. 2 antibodies crosn.reacted with 
the different parasite lines while 9 were specific for one line. Thin antigenic diversity was correlated with 
major differences in one dimensional peptide maps between the purified antigen from different linen of 
paranilen. The peptide maps also revealed some apparently conserved structure which may have been 
responsible for the antigeitic cross reactivit y . Using cloned lines of P. falciparum and a second series of 
monoclonal antibodies, ni mit aranti'genie and structural div tinny wanevi dent in the equival entantigen from 
the important human pathogen. These findings arc discussed with relationship to the induction of 
protective insmunity to malsess. 
Key words: P/os,nndium; Malaria'. Immunity; Strain specificity; Monoclonal antibody; Peptide mapping 
INTRODUCTION 
Immunity to malaria is fundamentally parasite species specific [I] and at least 
partially strain specific [2-4]. Is follows that considerable inter- and intra-species 
antigenic diversity can be expected in certain crucial parasite antigens. Recently, high 
molecular "eight polypepsides synthesised late in the erythrocytic cycle of a number 
of Plasmodiunt species have been implicated in she induction of proective immunity to 
malaria, Boyle et at [5] showed that passive transfer of monoclonal antibodies to a 250 
kDa polypeptide synthesised by the rodent malaria Plasmodium chabaudi inhibited 
parasite multiplication in vivo. Epstein et al [6] produced a monoclonal antibody 
against the simian parasite P. knotvlcsi which both recognised a 250 kDa polypeptide 
Abbreviations' SDS. sodium dodrcylnulphaie; Tnt. Tein (hydrosymethyl) amino enhane; bisacrylamide. 
N, N -mel hyle neb,sac tyld- lit! it. 




and inhibited parasite multiplication in vitro. By immunising monkeys with a purified 
74 kfla component from P. knowlcsi infected erythrocytes, Schmidt-Ullrtch et al. [7] 
were able to protect all vaccinated animals against an otherwise lethal P. knowlesi 
challenge. However, serum from the vaccinated animals precipitated parasite poly-
peptides up to 230 kDa which all showed extensive homology in tryptic peptide maps. 
It therefore appears that the inimunogen in question was an in vivo processing 
product of a high molecular weight precursor. Most convincingly, Holder and Free-
man [8] were able to confeLconsiderable protection against challenge to mice immuni-
sed with purified antigens of 230 or 235 kfla isolated from the rodent malaria P. yoelii. 
Evidence linking the findings with the two rodent species to an equivalent antigen in 
the human parasite P. falciparum has recently been obtained. Antigenic cross reactivi-
ty has been demonstrated between both the high molecular weight polypeptides of P. 
chabaudi (250 kDa) and P. yoelii(230 kDa) and a 195 kDa polypeptide synthesised at 
the same time in the cell cycle of P. falciporunt [9-I1]. 
In this study we have utilised a panel of monoclonal antibodies raised against the 
cloned line P. chabaudi 2722AS to investigate antigcnic diversity and cross-reactivity 
between this and a second cloned line of P. chabaudi from the same area ofAfrica. We 
have also compared structurally the 250 kDa antigen from the two parasite clones. In 
order to widen the relevance of our results to malaria in man, we have utilised a further 
series of monoclonal antibodies t 12 to investigate antigenic and structural diversity in 
an equivalent polypeptide from the human parasite P. falciporun,. 
MATERIALS AND METHODS 
Parasites. Three cloned lines of P. choboudi were used, 2722AS. CB and DS. All were 
obtained from D. Walliker (Edinburgh). Infections were initiated in 24-26 g male 
CRA mice by intraperitoneal inoculation of parasited erythrocytes from a large 
cryopreserved stock and used within five passages from this stabilate as described 
previously [13]. Mice were maintained in a controlled light/dark cycle with illumina-
tion between 17.30 h and 08.30 h to enable erythrocytes containing mature tropho-
zoites to be harvested in she morning [13]. Two cloned isolates of P. falciporuni. C I O 
and 07, were maintained in in vitro culture using standard techniques [14]. CIO was 
derived from a Gambian isolate BW and D7 wasderived from the Ugandan Palo Alto 
strain [14]. The two clones were antigenically distinct from each other as determined 
by indirect immunofluorescence with a panel of strain specific monoclonal antibodies, 
and the ansigenic phenotypes of the clones corresponded to those of the parental 
isolates (12). 
Sera and manor/anal antibodies. Normal and P. chabaudiAS immune mouse sera were 
obtained as described previously [15]. The preparation and characterisation of mono-
clonal antibodies to P. chabaudi 2722AS has been described previously [5]. The 
monoclonal antibodies directed against P. falciparum were those described by 
McBride et al[I 2]. For itomunopredipisatton or indirect immunofluorescence, ascitic 
fluid from hybridoma bearing mice was used at appropriate dilutions. 
Metobol,c label/mg of parasitisedery:/irocytes with [355'] nsethiontne, P. chabaudi parast-
tised erythrocytes at the mature trophozoite stage were obtained from mice with a 
parasitacmia of greater than 20%, The harvesting of parasites, removal of leucocytes 
and the 2 h in vitro labelling with r tS]melhionine was as described previously[ 13 ' 15]. 
Identical short term in vitro labelling conditions were used for sorbitol synchronised 
cultures of P. falciparinn at the mature trophoz.oite/young schizont stage 1161. 
Imutunoprectpitouon. Coprecipitation of metabolically labeled, Triton X-100 soluble 
parasite polypeptides with serum or monoclonal antibodies wascarried out as previous. 
ly described [5,15]. In all cases immunoprecipitations were performed on parasites 
labeled metabolically with [''S]nieshionine during the trophozoite to schizont transi-
tion. 
VS pro/ease tnapptng. Washed monoclonal antibody immunoprecipitates containing 
equal numbers of 1sS counts per minute were resuspended in 150-250 pl GTS buffer 
(0.05 M Tris/HCl, pH 7.5,0.5% sodium dodecylsulphate (SOS), 20% glycerol). They 
were subsequently incubated at 37°C with 60 gg mVt Staphylococcal V8 protease [17]. 
Samples were removed at intervals and digestion was halted by boiling for 5 min in 
two volumes of gel sample buffer (1% SOS, 50 m Tris/HCI, pH 7.5, I mM EDTA, 
5% 2-mercaptoethanol, 2 mM phenytmethyl sulphonyl fluoride, 10% glycerol). 
SDS-pol,yacrylantide gel elect rophoresis (SDS-PA GE). SOS gels containing either 10% 
or 12,5% w/v acrylamide were prepared and run as described previously [13] with the 
exception that for 12.5% gels, the ratio of acrylamide to bisacrylamide was 30:0.8. 
Gels were subsequently processed for fluorography [18]. 
Indirect inrnunoj7uorrscence. Indirect immunofluorescence staining of P. chabaudi 
parasited erythrocytes with monoclonal antibodies was as described [5]. 
RESULTS 
17 monoclonal antibodies raised against the AS clone ofP. ehabaodi had previously 
been characterised with regard to the parasite coded polypeptides to which they werr 
specific. II ofthesc antibodies recognised an antigen of 250 kDa synthesised late in the 
cell cycle and gave a characteristic pattern of indirect immunofluorescence on metha-
nol-fixed blood smears. In preliminary experiments, therefore, the reactivity of the 17 
antibodies with AS orCB parasites in indirect immunofluorescence wascompared. Of 
the II antibodies known to be directed against the 250 kDa antigen, 9 were found to 
react only with AS parasites (Nos. 2,3,4,12,14,15,16,18 and 20), but? cross-reacted 
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with CO parasites (Nos. I and 8). The 2 cross reacting antibodies gave typical patterns 
of indirect intmunofluorescence with both parasite clones. Fluorescence was observed 
around the membrane enclosing developing merozoites and/or free merozoites. The 
remaining 6 monoclonal antibodies, which were directed against oilier parasite anti-
gens of the AS line [5), all cross-reacted with the CB clone (data not shown). 
This immunouluorescencc data with the anti-250 kDa antibodies was confirmed by 
immunoprecipitation of late stage parasite polpeptides labelled metabolically with 
S methionine (Fig. 1(a)), Only monoclonal antibodies I and 8 reacted strongly with 
the CO line whereas, as expected, all II antibodies precipitated a parasite polypeptide 
of 250 kDa from AS parasites. In addition, when immunoprecipitates (not shown) or 
total metabolically labelled parasite lysates were run side by side, the molecular weight 
of the antigen recognised by the cross-reactive antibodies was approximately 5 kDa 
less in CO than in AS parasites (Fig. I (b)). Thus the equivalent antigen from to 
cloned lines of P. chabaud) showed both antigenic and molecular differences whilst at 
the same time conserved antigenic regions could be demonstrated. To investigate 
further the structural relationship between the corresponding polypeptides from the 
two isolates, monoclonal antibody 8 was used to precipitate [' 5S]methioriine-iabelled 
antigen from both parasite lines. The washed precipitates were then digested for 
various times with staphylococcal \'8 protease and the resultant polypeplides analy-
sed by SDS-PAGE and fluorography(Fig. 2). All ofthe peptides present in addition to 
the 250 kDa antigen in the time 0 tracks were subsequently shown to be derived from 
the 250 kDa polypcptide by pulse-chase experiments (Newbold and Schryer, unpu-
blished). Control experiments, where two different samples of antigen from the same 
parasite clone were mapped on one gel showed that under these conditions the 
digestion patterns were indistinguishable. 
Examination of the one dimensional maps reveals that the majority of major 
digestion products of the antigen from the two parasites are not obviously related.  
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suggesting that a high degree of structural diversity exists between this important 
antigen in two related parasite clones. However, some digestion products of the two 
antigens have the sante mobility (arrowed in Fig. 2) and therefore suggest common 
conserved structure that may be responsible for the cross reaction observed with two 
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Fig I. trttn noprcctpitaiion of metabolic ally labeled poiypcpiides of P. chubiwdi clones CO and .\S by 
monoclonal antibodies raised against clone AS (a) CIt or AS parasites were labelled for 2 h in Vitrodsiring 
he development of mature irophiszoitcs to schizonis. Triton X-I00 soluble CO or AS antigens sine 
irtrnunoprccipitarcd with monoclonal antibodies 1-4. 8, 12, 14-16, 18, 20. normal mouse serum (it) or 
risrnune serum direi.ted against AS parastins )i). The particular aseitie fluid containing clone 2 guns high 
non - specific background precipitation in his experiment. precipitates were analysed by SDS PAGE on a 
lOfi gel and visuahsrd by Iluorography. (b) Lysates of AS and CO parasites labcllcdasin )a)wcrcanalvsed 
hi SOS-PACt: on a lli gel and the labelled hands visualised b) Ilnorography. Molecular ssnight markers 
used throughout were human sprctrult (240 and 220 kDa), E. co/i RNA poivmncrase (165, 155 and 39 kDa). 
box ne serum albumin (68 kDa) and soybean irypsin inhibitor (21 kt)a) 
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Fig. 2. Staphylococcal VS protease digests of 250 tDa antigens from P. c/tabaudi clones AS arid CB 
Monoclonal antibody S was used to inirnunoprecipitate 250 kDa antigen labeled metabolically with 
l tSlmethiomne from CO or AS parasites as in Fig I Precipitates acre digested for various times 
a tb VS 
protease and analysed by SDS PAGE on a 10 gel. Labelled digestion products were visualised by 
Iluorography. From left to right, iracks are atiernatisely AS or CB antigen at 0.30 and 90 S and 5.15 and 30 
min digestion time. Peptides of equisaknt mobility derised from the antigen from the two parasite clones 
are armowed on the right 
Using the same mapping technique, the 250 kDa antigen from AS and CO parasite 
was compared with a third, geographically distinct cloned isolate of P. chabaudt 
designated DS. Since monoclonal antibody 8 also reacted with this line o[parasites. it 
could be used to imtnurioprccipitaie antigen from all three parasite clones. The 
resulting peptide map on a 12.5i- w/v aerylarnide SDS gel is shown in Fig. 3. It is 
evident that the same structural similarities are present in the third line of?. chobaudl. 
but that in other respects the antigen from the three different parasites shows conside- 
rable diversity in structure. 
It was pointed out in the introduction that similar high molecular weight antigens 
AS 	CS OS 	AS CS OS I AS CS OS AS CB OS I AS CS D5 
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Fig. 3. Staphylococcal VS protease digest of 250 kDa antigen from P. chabaud, clones AS. CO and DS. 
irs.l a he ll e d 250 kDu aniigcs was precipitated from parasite clones AS, CS and OS with monoclonal 
antibody as described its Fig 2. The precipitates were digested for various times with V8 troicase and the 
products analysed by SOS PAGE on a 25.5% gel. Labeled hands were visualised by lluorography. Samples 
5,-etc run in groups of three from left to right as follows: AS, CB. DSantigen at time 0, 30s.90s. 5 min and 20 
win. 
from the asexual intraervthrocytic cycle of a number of P/asrnod.'wn species have been 
implicated in the induction of protective immunity. The equivalence of the 250 kDa 
antigen from P. cltahaud,, the 230 kDa antigen from P. yoe'Iü and a 195 kDa polypep- 
tide from P. J'alciparum has recently been demonstrated by showing antigenic cross- 
reactivity between the molecules from the three different species [9]. McBride et al. 
1121 sad produced it number of monoclonal antibodies to P.falciparum which showed 
strain specificity and some of which recognised a parasite polypeptide of approxltna- 
tclv 200 Ii Da (9]. By  this and a number of other criteria (see Discussion) it was evident 
that at least some of these strain specific monoclonal antibodies recognised a P. 
Jislciporunt antigen which was equivalent to the 250 kDa cotsiponent ofP. cltohat,dt. It 
therefore of interest to determine whether or not the same structural diversity 
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shown by the antigen from the rodent parasites was also present in different cloned 
isolates of the human malaria. 
Clones C10 and D7 of P. J'alciparum were labelled metabolically with [ 3t Sjmethio. 
nine and parasite polvpeptides immunoprecipitated with three monoclonal antibodies 
(7.3, 9.2 and 9.8 112]). All precipitated components of approximately 200 kDa from 
the labeled schtzont infected cell extracts. Antibody 7.3 was specific for clone CIO, 9.2 
was specific for clone D7while the third antibody (9.8) cross-reacted with both 
parasites isolates (data not shown). This confirmed the immunofltioreseence specifici-
ties of the monoclonal antibodies described previously [12). The cross-reactive antibo-
dy [9.8) was therefore used to repeat the imm Lino precipitation and peptide mapping 
experiments described earlier (Fig. 4). It is evident that the antigen molecular weights 
from the two cloned isolates arc slightly different, as had been seen in the ease of the P. 
chabauril antigen Again, the peptides in addition to the 200 kDa bands in the time 0 
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Fig. 4. VS proiease digests 01 high insiirui.sr scaighi sChOorti antigen from T'.fokrpw-um clones Ctoand D7. 
P. falcrpai'um clones CIO and D 7  were labelled metabolically for 2 h with h"S]nethionine at the tate 
iroptsozoite/schizont stage Monoclonal antibody 9.8 112l was used to precipitate antigen from Triton 
X-tOO extracts of the labeled cells. The mrntsnnprecipitates were then digested for increasing Limes with V8 
proirase, the products analysed by SDS PAG1: on a 12.5"t gel and cisuatised by fluorography. Tracks front 
left to right are alternateiv antigen front clones CIO or D7 digested for 0.30 and 90s and 5, 15 and 30 mix. 
tracks are cleavage products of the tittilor atitigen and correspond closely in molecular 
weight to the processing products described by Holder and Freeman [10]. The map 
itself demonstrates apparently conserved peptides between the antigen from the two 
clones, but very considerable diversity in the other peptides produced during the 
digestion. 
DISCUSSION 
The evidence equating high molecular weight pi)lypeptides from various Plasnto-
dnirtt species is manifest in the follow i tip common features. They are all synthesised 
late in the itttracrsthrocytic cycle of the parasite (6-'hl,13,h5,16,19]. Monoclonal 
antibodies directed against these antigens show a characteristic pattern of indirect 
imnititiotluorescerice on methanol fixed blood smears. Fluorescence is observed 
around developing merozoitcS within schizonis and on free merozoitcs [5,6,8,10, 12, 
19]. Monoclonal antibody immunopreeipitates of metabolically labelled antigen 
either alone or in Conjunction with pulse-chase experiments suggest that these anti-
gens are cleaved post iranslationally in a specific fashion [5,8,9,10,19]. The antigens 
are lost during the process of schizotit rupture and rnerozoite invasion and are not 
carried through to the subsequent cell cycle as shown by pulse-chase experiments 
(16,20] and /or lack of monoclonal antibody reactivitywith ring stages [5,6,8,10). In a 
surface-specific imtounoprectpttittioti assay, these antigens were found to be available 
to bind attiibodv in undtst tiptcd schizont infected erythrocyte preparations of t%%0 
rodent matarias [15], in P. faleipurum [16] and in P. k,ioisIesi (unpublished observa-
tions, Newbold and Boyle). Finally, antigenic cross reactivity has been demonstrated 
between antigens from P. yoelii, P. diabaudi and P. fakiparuni [9]. 
A further feature of these antigens suggested by immunofluorescence data with 
monoclonal antibodies to 11. .fokiparunt [12], or here to P. citobaudj, is considerable 
antigcnic diverstis . In this study wit have extended these observations by dernonsira - 
tmg that both the antigenic diversity and cross reactivity in this family of high 
molecular ssciithti antigens can be represented at the structural level. Not only are there 
small differences in molecular weights between the antigens from different cloned 
lines of parasites, but one dimensional peptide imps reveal that apparently conserved 
sequences as well as completely diverse Structures are present within different para-
sites of a single species. Since cross-reactive antibodies were used in the mapping 
studies, it should be stressed that without the availability of other antibodies to the 
same antigen ofdifferent epitope specificity, or the data obtained by the peptide maps, 
it may have been concluded that the antigen from different parasite lines was identical. 
This may be a consideration when examining possible intraspecies diversity in other 
parasite antigens. 
However, the most important conclusions to be drawn from these experiments is 
how the antigenic and structural diversity in this family of plasmodial antigens relates 
to the induction of protective immunity. So far, vaccination studies with purified 
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antigen have clearly demonstrated protection against homologous parasite challenge 
with the 230 kDa antigen from I'. joe/ti [8]. In vitro inhibition of parasite multiplica-
tion has also been demonstrated with a monoclonal antibody directed against the 
equivalent 250 kDa antigen from P. knosr'Iesi[6]. By inference, the protection achieved 
by Schmid-Ullrich et al L1 using a 74 kDu P. knowiesi polypeptide for vaccination 
was very likely related to these findings, since vaccinated animals produced antibodies 
which recognised a family ofstructurallv related polypeptides up to 230 kDa, typical 
of the in vivo processing known to occur with this family of antigens. With P. 
chabaudi, passive transfer of anti 250 kDa monoclonal antibodies conferred a degree 
of protection to mice against challenge 51. Taken together with the data presented 
here, these findings suggest that: (I) this family of high molecular weight antigens is 
somehow involved in the induction of protective immunity to malaria. (2) The 
considerable antigenic and structural diversity in these antigens from at least two 
species of malaria is unlikely to he fortuitous. Since they seem to be involved at least in 
part in the induction of immunils . natural selection may well have resulted in the 
generation of diversity as one mechanism of evading the hosts immune response. (3) 
Vaccination studies with purified 250 kDa antigen from AS and CB lines of P. 
chabaudi suggest that the protection afforded to mice against challenge is also strain 
specific (Schryer, Newbold, Jarra and Brown, in preparation). 
Immunity to malaria involves a complex series of events and takes many years to 
acquire under conditions of natural transmission [I). It is characterised by compo-
nents which show strict parasite species specificity, at least partial strain specificity 
and, in some cases at least, variant specificity [1-4]. There are also components of the 
immune response, which appear to be non-specific in effect, that can confer a limited 
degree of protection across strain and species barriers [21,22]. Attempting to explain 
such a complex phenomenon in terms of an immune response to a single antigen 
would be simplistic in the extreme. Nevertheless, the fact that an antigen involved in 
the induction of immunity shows such inter- and intra-species diversity suggests that 
at least part of species and strain specific components of malarial immunity may be 
directed against this class high molecular weight parasite antigens. 
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